https://rovi.es/esdaily1.0 https://rovi.es/es/content/first-half-2017-results-press-release2021-10-10T10:53Znever https://rovi.es/es/content/incorporacion-tecnologo-programa-idi-gracias-al-programa-emplea2025-07-22T11:24Zyearly https://rovi.es/es/content/home-52017-06-27T12:17Znever https://rovi.es/es/content/about-page2017-06-27T12:18Znever https://rovi.es/es/content/service-page2017-06-27T12:16Znever https://rovi.es/es/content/team-page2017-06-27T12:18Znever https://rovi.es/es/content/home-boxed2017-06-27T12:18Znever https://rovi.es/es/content/home-header-absolute2017-06-27T12:13Znever https://rovi.es/es/rovi2017-09-26T15:31Znever https://rovi.es/es/productos2017-09-13T07:04Znever https://rovi.es/es/fabricación2025-08-08T15:35Zyearly https://rovi.es/es/i-d2025-08-28T11:03Zyearly https://rovi.es/es/content/publicación-de-los-resultados-financieros-del-ejercicio-20102021-10-10T10:51Znever https://rovi.es/es/content/publicación-de-los-resultados-financieros-del-primer-trimestre-de-20112021-10-10T10:51Znever https://rovi.es/es/content/publicación-de-los-resultados-financieros-del-primer-semestre-de-20112021-10-10T10:51Znever https://rovi.es/es/content/publicación-de-los-resultados-financieros-del-período-de-9-meses-finalizado-el-30-de2021-11-03T15:50Znever https://rovi.es/es/content/seminario-de-small-caps-españoles-de-santander2021-10-10T10:51Znever https://rovi.es/es/content/resultados-enero-diciembre-20112021-10-10T10:51Znever https://rovi.es/es/content/crédit-suisse-global-healthcare-conference2021-10-10T10:51Znever https://rovi.es/es/content/resultados-enero-marzo-20122021-10-10T10:51Znever https://rovi.es/es/content/8º-foro-medcap2021-10-10T10:51Znever https://rovi.es/es/content/8º-foro-medcap-02021-10-10T10:51Znever https://rovi.es/es/content/resultados-enero-junio-20122021-10-10T10:51Znever https://rovi.es/es/content/morgan-stanley-global-healthcare-conference2021-10-10T10:51Znever https://rovi.es/es/medios2017-09-21T10:12Znever https://rovi.es/es/content/ubs-global-life-sciences-conference2021-10-10T10:51Znever https://rovi.es/es/content/seminario-de-small-caps-españoles-de-banesto2021-10-10T10:51Znever https://rovi.es/es/content/resultados-enero-septiembre-20122021-10-10T10:51Znever https://rovi.es/es/content/jefferies-global-healthcare-conference2021-10-10T10:51Znever https://rovi.es/es/content/seminario-de-small-caps-españoles-de-santander-02021-10-10T10:51Znever https://rovi.es/es/content/resultados-financieros-del-ejercicio-20122021-10-10T10:51Znever https://rovi.es/es/content/crédit-suisse-global-healthcare-conference-02021-10-10T10:51Znever https://rovi.es/es/content/resultados-enero-marzo-20132021-10-10T10:51Znever https://rovi.es/es/trabaja-con-nosotros2024-10-01T15:07Zyearly https://rovi.es/es/content/seminario-de-small-caps-españoles-de-banesto-02021-10-10T10:51Znever https://rovi.es/es/content/ubs-global-healthcare-conference2021-10-10T10:51Znever https://rovi.es/es/content/ix-foro-medcap2021-10-10T10:51Znever https://rovi.es/es/content/resultados-financieros-del-primer-semestre-de-20132021-10-10T10:51Znever https://rovi.es/es/content/morgan-stanley-global-healthcare-conference-02021-10-10T10:51Znever https://rovi.es/es/content/4th-bbva-iberian-conference2021-10-10T10:51Znever https://rovi.es/es/content/cheuvreux-2013-autumn-conference2021-10-10T10:51Znever https://rovi.es/es/content/resultados-enero-septiembre-20132021-10-10T10:51Znever https://rovi.es/es/estructura-societaria2025-05-05T11:58Zyearly https://rovi.es/es/content/santander-iberian-conference-madrid2021-10-10T10:51Znever https://rovi.es/es/content/resultados-financieros-del-ejercicio-20132021-10-10T10:51Znever https://rovi.es/es/content/credit-suisse-healthcare-conference-londres2021-10-10T10:51Znever https://rovi.es/es/content/ubs-healthcare-conference-nueva-york2021-10-10T10:51Znever https://rovi.es/es/content/foro-medcap-bolsa-de-madrid2021-10-10T10:51Znever https://rovi.es/es/content/foro-medcap-bolsa-de-madrid-02021-10-10T10:51Znever https://rovi.es/es/content/junta-general-de-accionistas2021-10-10T10:51Znever https://rovi.es/es/content/iii-spanish-smallmid-cap-conference-nueva-york2021-10-10T10:51Znever https://rovi.es/es/laboratorio-de-historia2023-07-14T08:55Znever https://rovi.es/es/content/resultados-enero-junio-20142021-10-10T10:51Znever https://rovi.es/es/content/morgan-stanley-healthcare-conference-nueva-york2021-10-10T10:51Znever https://rovi.es/es/content/bbva-iberian-day-londres2021-10-10T10:51Znever https://rovi.es/es/content/kepler-cheuvreux-autumn-conference-parís2021-10-10T10:51Znever https://rovi.es/es/content/resultados-enero-septiembre-20142021-10-10T10:51Znever https://rovi.es/es/content/jefferies-2014-global-healthcare-conference-londres2021-10-10T10:51Znever https://rovi.es/es/content/jefferies-2014-global-healthcare-conference-londres-02021-10-10T10:51Znever https://rovi.es/es/content/resultados-financieros-del-ejercicio-20142021-10-10T10:51Znever https://rovi.es/es/unidades-de-negocio2023-10-19T09:20Znever https://rovi.es/es/content/credit-suisse-one-one-healthcare-conference-londres2021-10-10T10:51Znever https://rovi.es/es/content/credit-suisse-one-one-healthcare-conference-londres-02021-10-10T10:51Znever https://rovi.es/es/content/resultados-enero-marzo-20152021-10-10T10:51Znever https://rovi.es/es/content/ubs-global-healthcare-conference-nueva-york2021-10-10T10:51Znever https://rovi.es/es/content/ubs-global-healthcare-conference-nueva-york-02021-10-10T10:51Znever https://rovi.es/es/content/ubs-global-healthcare-conference-nueva-york-12021-10-10T10:51Znever https://rovi.es/es/content/resultados-financieros-del-primer-semestre-de-20152021-10-10T10:51Znever https://rovi.es/es/content/jefferies-global-healthcare-conference-02021-10-10T10:51Znever https://rovi.es/es/estrategia2024-08-07T10:14Zyearly https://rovi.es/es/content/resultados-financieros-del-ejercicio-20152021-10-10T10:51Znever https://rovi.es/es/content/credit-suisse-global-healthcare-conference-12021-10-10T10:51Znever https://rovi.es/es/content/credit-suisse-global-healthcare-conference-22021-10-10T10:51Znever https://rovi.es/es/content/resultados-financieros-del-primer-semestre-20162021-10-10T10:51Znever https://rovi.es/es/content/bbva-conference-london2021-10-10T10:51Znever https://rovi.es/es/content/kepler-cheuvreux-autumn-conference-parís-02021-10-10T10:51Znever https://rovi.es/es/content/resultados-enero-septiembre-20162021-10-10T10:51Znever https://rovi.es/es/content/resultados-financieros-del-ejercicio-20162021-10-10T10:51Znever https://rovi.es/es/content/resultados-financieros-del-primer-trimestre-20172021-10-10T10:51Znever https://rovi.es/es/licencias2017-09-26T15:35Znever https://rovi.es/es/content/junta-general-de-accionistas-de-rovi-20172021-10-10T10:51Znever https://rovi.es/es/content/pago-de-dividendos2021-10-10T10:51Znever https://rovi.es/es/content/resultados-financieros-del-primer-semestre-20172021-10-10T10:51Znever https://rovi.es/es/responsabilidad-corporativa2017-06-27T12:13Znever https://rovi.es/es/eventos-futuros2017-06-27T12:13Znever https://rovi.es/es/último-informe-financiero2017-06-27T12:18Znever https://rovi.es/es/información-general-sobre-la-empresa2017-06-27T12:18Znever https://rovi.es/es/fabricación-a-terceros2025-08-08T16:53Zyearly https://rovi.es/es/fabricación-propia2025-08-08T16:26Zyearly https://rovi.es/es/pipeline2017-09-09T10:57Znever https://rovi.es/es/ism2021-07-23T13:09Znever https://rovi.es/es/rsc2018-01-18T16:57Znever https://rovi.es/es/misión-visión-y-valores2019-01-28T12:52Znever https://rovi.es/es/relaciones-con-los-grupos-de-interés2022-07-29T09:58Znever https://rovi.es/es/compromiso-con-la-sociedad2023-02-02T09:08Znever https://rovi.es/es/transparencia2017-06-27T12:19Znever https://rovi.es/es/expansión-internacional2023-11-10T11:23Znever https://rovi.es/es/productos-de-prescripción2025-10-31T07:14Zyearly https://rovi.es/es/productos-hospitalarios2023-12-19T10:03Znever https://rovi.es/es/glicómica2021-07-23T12:06Znever https://rovi.es/es/tecnología-multicapas-de-aplicación-catéteres-uretrales2017-09-23T10:47Znever https://rovi.es/es/cauces-de-comunicación-con-la-sociedad2021-12-30T10:08Znever https://rovi.es/es/la-acción-y-su-capital-social2021-12-30T10:08Znever https://rovi.es/es/agenda-del-inversor2021-12-30T10:09Znever https://rovi.es/es/dividendos2021-12-30T10:09Znever https://rovi.es/es/ofertas-públicas-de-venta-y-admisión-de-valores2021-12-30T10:09Znever https://rovi.es/es/ofertas-públicas-de-adquisición-de-valores-opa2021-12-30T10:09Znever https://rovi.es/es/estatutos2021-12-30T10:09Znever https://rovi.es/es/hechos-relevantes2021-12-30T10:10Znever https://rovi.es/es/calculadora2021-12-30T10:13Znever https://rovi.es/es/pactos-parasociales2021-12-30T10:10Znever https://rovi.es/es/content/presentación-de-resultados-del-primer-semestre-de-20172021-10-10T10:53Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-primer-semestre-de-20172021-10-10T10:53Znever https://rovi.es/es/participaciones-significativas-y-autocartera2021-12-30T10:10Znever https://rovi.es/es/cobertura-por-analistas2021-12-30T10:10Znever https://rovi.es/es/informe-de-auditoria-cuentas-anuales-auditadas-individuales-y-consolidadas-informe-de2021-12-30T10:12Znever https://rovi.es/es/información-pública-periódica2021-12-30T10:11Znever https://rovi.es/es/información-remitida-con-el-carácter-de-pública-otros-organismos-reguladores-en-el-supuesto2021-12-30T10:12Znever https://rovi.es/es/rating2021-12-30T10:12Znever https://rovi.es/es/periodo-medio-de-pago-proveedores2021-12-30T10:12Znever https://rovi.es/es/foro-de-accionistas2021-05-13T08:06Znever https://rovi.es/es/junta-general-de-accionistas-ejercicio-del-derecho-de-información2021-12-30T10:15Znever https://rovi.es/es/medios-contacto2026-01-27T12:05Zyearly https://rovi.es/es/convocatoria-y-orden-del-día-de-la-junta2021-12-30T10:15Znever https://rovi.es/es/últimos-resultados2025-07-22T11:23Zyearly https://rovi.es/es/solicitudes-de-información-o-aclaraciones-solicitadas-por-los-accionistas2021-12-30T10:16Znever https://rovi.es/es/delegaciones-de-voto2021-12-30T10:16Znever https://rovi.es/es/voto-distancia-en-las-juntas-generales2021-12-30T10:16Znever https://rovi.es/es/información-sobre-el-desarrollo-de-las-juntas-generales2021-12-30T10:16Znever https://rovi.es/es/_reglamento-del-consejo2017-07-27T13:33Znever https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-20172025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-20172025-07-22T11:24Zyearly https://rovi.es/es/informe-anual-de-gobierno-corporativo2021-12-30T10:17Znever https://rovi.es/es/remuneraciones-de-los-consejeros2021-12-30T10:17Znever https://rovi.es/es/comisiones-del-consejo2021-12-30T10:18Znever https://rovi.es/es/políticas-corporativas-old2017-07-15T10:41Znever https://rovi.es/es/content/nota-de-prensa-de-los-resultados-9m-20172021-10-10T10:53Znever https://rovi.es/es/content/presentación-de-resultados-9m-20172021-10-10T10:53Znever https://rovi.es/es/content/presentación-del-proyecto-de-risperidona-ism®2017-11-29T09:35Znever https://rovi.es/es/webcast-y-presentaciones2021-12-30T10:27Znever https://rovi.es/es/content/presentación-de-resultados-enero-septiembre-20172017-11-29T09:42Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-de-enero-septiembre-de-20172017-12-13T10:00Znever https://rovi.es/es/content/crédito-otorgado-por-el-banco-europeo-de-inversiones-rovi2017-12-21T17:02Znever https://rovi.es/es/content/acuerdo-rovi-bei2021-11-08T10:56Znever https://rovi.es/es/content/resultados-financieros-del-ejercicio-20172021-10-10T10:51Znever https://rovi.es/es/compromiso-con-el-medio-ambiente2023-03-07T09:46Znever https://rovi.es/es/compromiso-con-los-empleados2023-05-08T08:03Znever https://rovi.es/es/faqs2022-06-29T14:27Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-ejercicio-20172021-11-02T17:20Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-ejercicio-2017-02018-02-20T08:29Znever https://rovi.es/es/noticias2022-06-29T14:27Znever https://rovi.es/es/detalle-noticia2017-07-06T08:29Znever https://rovi.es/es/content/presentación-de-resultados-del-ejercicio-20172018-02-20T08:29Znever https://rovi.es/es/content/presentación-de-resultados-del-ejercicio-2017-02021-11-02T17:20Znever https://rovi.es/es/content/presentacion-sobre-doriar2021-11-08T10:57Znever https://rovi.es/es/información-de-contacto2024-04-12T09:27Zyearly https://rovi.es/es/content/rovi-anuncia-un-acuerdo-con-hikma-para-distribuir-y-comercializar-su-biosimilar-de2018-04-24T07:51Znever https://rovi.es/es/content/rovi-anuncia-un-acuerdo-con-hikma-para-distribuir-y-comercializar-su-biosimilar-de-02021-10-10T10:53Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-primer-trimestre-de-20182018-04-25T06:28Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-primer-trimestre-de-2018-02021-11-02T17:17Znever https://rovi.es/es/content/presentación-de-resultados-del-primer-trimestre-de-20182021-11-02T17:17Znever https://rovi.es/es/aumento-de-capital2025-07-22T11:22Zyearly https://rovi.es/es/content/rovi-anuncia-un-acuerdo-con-sandoz-para-distribuir-y-comercializar-su-biosimilar-de2018-06-12T10:17Znever https://rovi.es/es/content/rovi-anuncia-un-acuerdo-con-sandoz-para-distribuir-y-comercializar-su-biosimilar-de-02021-11-02T17:21Znever https://rovi.es/es/content/concesión-de-ayuda-cofinanciada-por-el-fondo-europeo-de-desarrollo-regional-feder2018-06-20T12:01Znever https://rovi.es/es/content/resultados-financieros-del-primer-semestre-de-20182021-10-10T10:51Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-primer-semestre-de-20182018-07-26T05:59Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-primer-semestre-de-2018-02021-11-02T17:14Znever https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-20182021-11-08T10:59Znever https://rovi.es/es/content/enervit-ejercita-la-opción-de-compra-del-1-de-enervit-nutrition-joint-venture-de-rovi-y2018-07-27T06:23Znever https://rovi.es/es/content/enervit-ejercita-la-opción-de-compra-del-1-de-enervit-nutrition-joint-venture-de-rovi-y-02021-11-02T17:13Znever https://rovi.es/es/content/rovi-ha-iniciado-la-comercialización-de-su-biosimilar-de-enoxaparina-en-españa2018-09-19T10:34Znever https://rovi.es/es/content/rovi-ha-iniciado-la-comercialización-de-su-biosimilar-de-enoxaparina-en-españa-02021-11-02T17:10Znever https://rovi.es/es/content/rovi-anuncia-un-acuerdo-con-biogaran-para-comercializar-su-biosimilar-de-enoxaparina-en2018-09-20T07:14Znever https://rovi.es/es/content/rovi-anuncia-un-acuerdo-con-biogaran-para-comercializar-su-biosimilar-de-enoxaparina-en-02021-11-02T17:10Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-de-los-primeros-nueve-meses-de-20182018-11-06T07:08Znever https://rovi.es/es/content/nota-de-prensa-de-los-resultados-9m-20182021-11-02T17:09Znever https://rovi.es/es/content/presentación-de-resultados-9m-20182021-11-02T17:09Znever https://rovi.es/es/content/rovi-adquiere-falithrom®-para-el-mercado-alemán2019-01-09T07:14Znever https://rovi.es/es/content/rovi-adquiere-falithromr-para-mercado-aleman2021-11-10T16:39Znever https://rovi.es/es/content/resultados-financieros-del-ejercicio-20182021-10-10T10:51Znever https://rovi.es/es/content/concesión-de-ayuda-cofinanciada-por-el-fondo-europeo-de-desarrollo-regional-feder-02021-11-02T17:19Znever https://rovi.es/es/content/rovi-adquiere-los-derechos-para-maleato-de-dexclorfeniramina-en-los-mercados-español-y2019-02-15T07:53Znever https://rovi.es/es/content/rovi-adquiere-derechos-para-maleato-dexclorfeniramina-mercados-espanol-frances2021-11-10T16:39Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-ejercicio-20182019-02-26T07:06Znever https://rovi.es/es/content/rovi-logra-incremento-del-10-ingresos-operativos-apoyado-comportamiento-su-division2021-11-10T16:39Znever https://rovi.es/es/content/presentacion-resultados-del-ejercicio-20182021-11-26T10:05Znever https://rovi.es/es/front2017-06-27T12:32Znever https://rovi.es/es/content/avance-de-los-principales-resultados-positivos-del-estudio-en-fase-3-de-doria®-en-pacientes2019-03-19T06:55Znever https://rovi.es/es/content/avance-principales-resultados-positivos-del-estudio-fase-3-doriar-pacientes-con2021-11-10T15:52Znever https://rovi.es/es/content/avance-de-los-principales-resultados-positivos-del-estudio-en-fase-3-de-doria-en-pacientes2021-10-10T10:51Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-primer-trimestre-de-20192019-05-08T06:51Znever https://rovi.es/es/content/rovi-logra-incremento-del-8-ingresos-operativos-apoyado-comportamiento-su-division-heparinas2021-11-10T15:48Znever https://rovi.es/es/content/presentacion-resultados-del-primer-trimestre-20192022-01-13T09:49Znever https://rovi.es/es/content/la-familia-lópez-belmonte-amplía-su-participación-en-rovi-hasta-el-6312019-05-27T16:05Znever https://rovi.es/es/content/familia-lopez-belmonte-amplia-su-participacion-rovi-hasta-6312021-11-10T15:41Znever https://rovi.es/es/content/resultados-financieros-del-primer-semestre-de-20192021-10-10T10:51Znever https://rovi.es/es/content/rovi-anuncia-la-finalización-del-programa-de-investigación-clínica-que-apoyará-la-solicitud2019-07-05T06:24Znever https://rovi.es/es/content/rovi-anuncia-finalizacion-del-programa-investigacion-clinica-apoyara-solicitud-autorizacion2021-11-10T15:35Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-primer-semestre-de-20192019-07-30T05:56Znever https://rovi.es/es/content/rovi-logra-incremento-del-21-ingresos-operativos-del-99-ebitda2021-11-10T15:47Znever https://rovi.es/es/content/presentación-de-resultados-del-primer-semestre-de-20192021-11-02T16:55Znever https://rovi.es/es/content/rovi-anuncia-la-construcción-de-una-segunda-planta-de-heparinas-en-granada2019-09-05T10:13Znever https://rovi.es/es/content/rovi-anuncia-construccion-segunda-planta-heparinas-granada2021-11-10T14:44Znever https://rovi.es/es/content/resultados-enero-septiembre-20192021-10-10T10:51Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-de-los-primeros-nueve-meses-de-20192019-11-07T06:52Znever https://rovi.es/es/content/rovi-logra-incremento-del-24-ingresos-operativos-del-83-ebitda2021-11-10T15:47Znever https://rovi.es/es/content/presentación-día-del-inversor-2019-02021-11-01T11:23Znever https://rovi.es/es/content/vídeo-de-resultados-financieros-tercer-trimestre-2019-02021-11-01T11:24Znever https://rovi.es/es/content/rovi-anuncia-el-inicio-del-proceso-de-evaluación-para-la-obtención-de-la-autorización-de2020-01-31T07:23Znever https://rovi.es/es/content/rovi-anuncia-inicio-del-proceso-evaluacion-para-obtencion-autorizacion-comercializacion2021-11-16T06:49Znever https://rovi.es/es/content/resultados-financieros-del-ejercicio-20192021-10-10T10:51Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-ejercicio-20192020-02-26T07:30Znever https://rovi.es/es/content/rovi-logra-incremento-del-26-ingresos-operativos-del-106-ebitda2021-11-16T06:47Znever https://rovi.es/es/content/presentación-de-resultados-del-ejercicio-20192021-11-02T16:39Znever https://rovi.es/es/content/nota-de-prensa-concesión-de-ayuda2021-11-02T17:11Znever https://rovi.es/es/content/rovi-donara-millon-mascarillas-quirurgicas-al-ministerio-sanidad2021-11-16T06:44Znever https://rovi.es/es/content/rovi-informa-sobre-el-impacto-del-covid-19-en-las-actividades-de-la-compañía2020-04-02T15:53Znever https://rovi.es/es/content/rovi-informa-sobre-impacto-del-covid-19-actividades-compania2021-11-16T06:42Znever https://rovi.es/es/content/rovi-firma-un-convenio-de-colaboración-para-la-realización-de-un-ensayo-clínico-sobre-la2020-04-14T06:13Znever https://rovi.es/es/content/rovi-firma-convenio-colaboracion-para-realizacion-ensayo-clinico-sobre-eficacia-seguridad2021-11-16T06:39Znever https://rovi.es/es/content/resultados-enero-marzo-20202021-10-10T10:51Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-primer-trimestre-de-20202020-05-13T06:08Znever https://rovi.es/es/content/rovi-logra-incremento-del-23-ingresos-operativos-del-68-ebitda2021-11-16T06:38Znever https://rovi.es/es/content/presentación-de-resultados-del-primer-trimestre-de-2020-02021-11-02T16:37Znever https://rovi.es/es/content/resultados-financieros-del-primer-semestre-de-20202021-10-10T10:51Znever https://rovi.es/es/content/rovi-y-moderna-anuncian-la-colaboración-para-la-fabricación-fuera-de-estados-unidos-del2020-07-09T11:58Znever https://rovi.es/es/content/rovi-moderna-anuncian-colaboracion-para-fabricacion-fuera-estados-unidos-del-llenado-acabado2021-11-16T06:35Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-primer-semestre-de-20202020-07-27T05:53Znever https://rovi.es/es/content/rovi-logra-incremento-del-8-ingresos-operativos-del-83-del-beneficio-neto2021-11-15T18:19Znever https://rovi.es/es/content/presentación-de-resultados-del-primer-semestre-de-20202021-11-02T16:35Znever https://rovi.es/es/content/rovi-obtiene-2o-puesto-rating-sostenibilidad-nivel-mundial-02021-11-15T18:15Znever https://rovi.es/es/content/resultados-enero-septiembre-20202021-10-10T10:51Znever https://rovi.es/es/content/rovi-celebra-su-junta-general-accionistas-20202021-11-15T18:13Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-de-los-nueve-primeros-meses-de-20202020-11-05T07:10Znever https://rovi.es/es/content/nota-de-prensa-de-los-resultados-de-los-nueve-primeros-meses-de-20202021-11-02T16:11Znever https://rovi.es/es/content/presentación-de-resultados-de-los-nueve-primeros-meses-de-2020-02021-11-02T16:10Znever https://rovi.es/es/content/rov-logra-incremento-del-12-ingresos-operativos-del-53-del-beneficio-neto2021-11-15T18:09Znever https://rovi.es/es/content/la-revista-npj-schizophrenia-publica-los-resultados-del-estudio-prisma-3-sobre-la-eficacia-y2020-11-27T07:25Znever https://rovi.es/es/content/revista-npj-schizophrenia-publica-resultados-del-estudio-prisma-3-sobre-eficacia-seguridad2021-11-15T17:58Znever https://rovi.es/es/content/presidente-del-gobierno-espana-pedro-sanchez-realiza-visita-institucional-fabrica-rovi-san2021-11-15T18:00Znever https://rovi.es/es/content/rovi-completa-fabricacion-primeros-lotes-vacuna-moderna-para-ue2022-01-13T09:38Znever https://rovi.es/es/content/resultados-financieros-del-ejercicio-20202021-10-10T10:51Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-ejercicio-20202021-02-24T07:03Znever https://rovi.es/es/content/rovi-logra-incremento-del-10-ingresos-operativos-del-55-del-beneficio-neto2021-11-12T13:15Znever https://rovi.es/es/content/concesión-de-una-ayuda-parcialmente-reembolsable-para-el-desarrollo-de-una-nueva-formulación2021-11-02T16:20Znever https://rovi.es/es/content/incorporacion-dos-doctores-al-area-id-dentro-del-programa-torres-quevedo-convocatoria-del2021-11-15T18:10Znever https://rovi.es/es/content/actualización-de-los-procesos-de-registro-de-doria®2021-03-02T07:12Znever https://rovi.es/es/content/actualización-de-los-procesos-de-registro-de-doria®-12021-10-10T10:51Znever https://rovi.es/es/resultados-financieros-del-ejercicio-20162021-10-10T10:51Znever https://rovi.es/es/content/incorporación-de-un-doctor-al-área-de-id-dentro-del-programa-torres-quevedo-convocatoria-del2021-03-09T17:55Znever https://rovi.es/es/content/incorporacion-doctor-al-area-id-dentro-del-programa-torres-quevedo2022-01-13T09:52Znever https://rovi.es/es/content/rovi-participa-en-la-fabricación-del-principio-activo-de-la-vacuna-contra-la-covid-19-de2021-04-12T06:38Znever https://rovi.es/es/content/rovi-participa-fabricacion-del-principio-activo-vacuna-contra-covid-19-moderna2021-11-12T13:11Znever https://rovi.es/es/content/resultados-enero-marzo-20212021-10-10T10:51Znever https://rovi.es/es/content/rovi-incrementa-su-capacidad-de-llenado-y-acabado-de-la-vacuna-contra-la-covid-19-de-moderna2021-04-29T05:08Znever https://rovi.es/es/content/rovi-incrementa-su-capacidad-llenado-acabado-vacuna-contra-covid-19-moderna2021-11-12T13:10Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-primer-trimestre-de-20212021-05-13T05:44Znever https://rovi.es/es/content/rovi-logra-incremento-del-29-ingresos-operativos-del-74-del-ebitda2021-11-12T13:08Znever https://rovi.es/es/content/presentación-de-resultados-del-primer-trimestre-de-20212021-11-02T14:30Znever https://rovi.es/es/evolución-de-la-acción2025-07-22T11:23Zyearly https://rovi.es/es/histórico-de-la-cotización-bursátil2025-07-22T11:23Zyearly https://rovi.es/es/valor-de-la-acción2025-07-22T11:23Zyearly https://rovi.es/es/información-económica2025-07-22T11:23Zyearly https://rovi.es/es/content/presidente-del-gobierno-espana-pedro-sanchez-realiza-visita-institucional-instalaciones-rovi2021-11-12T13:05Znever https://rovi.es/es/content/concesión-de-una-ayuda-parcialmente-reembolsable-para-el-desarrollo-de-una-nueva-02021-05-17T15:37Znever https://rovi.es/es/content/rovi-celebra-su-junta-general-accionistas-20212021-11-12T12:40Znever https://rovi.es/es/biosimilar-de-enoxaparina2025-08-04T15:35Zyearly https://rovi.es/es/content/resultados-financieros-del-primer-semestre-de-20212021-10-10T10:51Znever https://rovi.es/es/informes-anuales2025-07-22T11:23Zyearly https://rovi.es/es/content/nota-de-prensa-de-resultados-del-primer-semestre-de-20212021-07-28T05:57Znever https://rovi.es/es/content/rovi-logra-incremento-del-52-ingresos-operativos-del-75-del-ebitda2021-11-12T12:35Znever https://rovi.es/es/content/presentación-de-resultados-del-primer-semestre-de-2021-02021-11-02T12:35Znever https://rovi.es/es/notas-de-prensa2021-12-30T10:26Znever https://rovi.es/es/_información-para-el-inversor2017-07-26T08:43Znever https://rovi.es/es/content/rovi-obtiene-2o-puesto-rating-sostenibilidad-nivel-mundial2021-11-12T12:32Znever https://rovi.es/es/content/rovi-obtiene-el-2º-puesto-en-un-rating-de-sostenibilidad-nivel-mundial-02021-08-09T08:05Znever https://rovi.es/es/content/rovi-informa-sobre-la-notificación-de-detección-de-partículas-en-determinados-viales-de-la2021-08-26T16:07Znever https://rovi.es/es/content/rovi-informa-sobre-notificacion-deteccion-particulas-determinados-viales-vacuna-contra-covid2021-11-12T12:28Znever https://rovi.es/es/content/rovi-informa-sobre-la-evolución-de-la-investigación-acerca-de-la-detección-de-partículas-en2021-08-29T20:50Znever https://rovi.es/es/content/rovi-informa-sobre-evolucion-investigacion-acerca-deteccion-particulas-determinados-viales2022-01-13T09:36Znever https://rovi.es/es/content/rovi-informa-del-comunicado-conjunto-de-moderna-y-takeda-en-relación-con-la-investigación2021-09-01T19:42Znever https://rovi.es/es/content/rovi-informa-del-comunicado-conjunto-moderna-takeda-relacion-con-investigacion-sobre-lotes2021-12-15T15:54Znever https://rovi.es/es/accionistas-inversores2022-06-20T11:16Znever https://rovi.es/es/accionistas-inversores/calendario2021-09-28T09:48Znever https://rovi.es/es/accionistas-inversores/gobierno-corporativo2025-06-23T12:14Zyearly https://rovi.es/es/accionistas-inversores/comunicaciones-cmnv2021-12-03T09:47Znever https://rovi.es/es/content/presentación-de-resultados-del-primer-trimestre-de-20172021-10-10T10:53Znever https://rovi.es/es/content/biosimilar-enoxaparina-gran-oportunidad-para-rovi2025-07-22T11:24Zyearly https://rovi.es/es/accionistas-inversores/gobierno-corporativo/voto-distancia2025-05-08T00:11Zyearly https://rovi.es/es/accionistas-inversores/gobierno-corporativo/convocatoria2025-05-07T22:14Zyearly https://rovi.es/es/accionistas-inversores/gobierno-corporativo/delegacion-voto2025-05-08T00:07Zyearly https://rovi.es/es/accionistas-inversores/gobierno-corporativo/politicas-corporativas2025-07-29T09:29Zyearly https://rovi.es/es/accionistas-inversores/gobierno-corporativo/remuneracion2026-02-25T09:46Zmonthly https://rovi.es/es/accionistas-inversores/la-accion/informacion2025-05-14T16:49Zyearly https://rovi.es/es/accionistas-inversores/gobierno-corporativo/comisiones2025-05-08T00:23Zyearly https://rovi.es/es/content/header-noticia-detalle2017-07-14T15:58Znever https://rovi.es/es/accionistas-inversores/gobierno-corporativo/textos-completos2021-12-01T17:34Znever https://rovi.es/es/accionistas-inversores/esg2021-10-20T11:27Znever https://rovi.es/es/accionistas-inversores/gobierno-corporativo/informe-anual-gb2026-02-25T09:45Zmonthly https://rovi.es/es/accionistas-inversores/gobierno-corporativo/composicion2022-12-19T12:20Znever https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-2017-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-sobre-biosimilar-enoxaparina-rovi2025-07-22T11:24Zyearly https://rovi.es/es/accionistas-inversores/gobierno-corporativo/foro-accionistas2025-05-08T00:16Zyearly https://rovi.es/es/content/rovi-finaliza-con-resultado-positivo-procedimiento-descentralizado-para-registro-su2025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-20162025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-dia-del-mercado-capitales-20212021-12-13T17:20Znever https://rovi.es/es/content/programa-recompra-acciones-rovi2021-12-15T12:05Znever https://rovi.es/es/content/nota-prensa-resultados-nueve-primeros-meses-20212021-12-16T16:44Znever https://rovi.es/es/content/fda-retrasa-decision-sobre-risperidona-ismr2021-12-15T15:53Znever https://rovi.es/es/content/presentacion-resultados-del-ejercicio-20162025-07-22T11:24Zyearly https://rovi.es/es/content/oddo-bhf-forum-20222021-11-29T08:55Znever https://rovi.es/es/content/xxviii-santander-iberian-conference2021-11-29T08:55Znever https://rovi.es/es/content/12th-spain-investors-day-ceo-conference2021-11-30T12:19Znever https://rovi.es/es/content/incorporacion-dos-doctores-al-area-id-dentro-del-programa-torres-quevedo2025-07-22T11:24Zyearly https://rovi.es/es/content/cmd-20212021-12-15T11:55Znever https://rovi.es/es/content/resultados-financieros-nueve-primeros-meses-20212021-12-15T12:00Znever https://rovi.es/es/content/rovi-anuncia-acuerdo-comercializacion-neparvis-espana2025-07-22T11:24Zyearly https://rovi.es/es/accionistas-inversores/gobierno-corporativo/solicitudes-informacion2021-12-03T10:10Znever https://rovi.es/es/content/nota-prensa-resultados-del-periodo-9-meses-finalizado-30-septiembre-20162025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-periodo-9-meses-finalizado-30-septiembre-20162025-07-22T11:24Zyearly https://rovi.es/es/accionistas-inversores/gobierno-corporativo/desarrollo-junta2025-06-23T11:45Zyearly https://rovi.es/es/content/rovi-anuncia-acuerdo-comercializacion-mysimba-espana2025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-20162025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-trimestre-20172025-07-22T11:23Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-20172025-07-22T11:23Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-20162025-07-22T11:24Zyearly https://rovi.es/es/textos-completos-de-las-propuestas-de-acuerdos-a-tomar-y-de-la-documentación-disponible-para-el-accionista-con-anterioridad-a-la-junta2021-12-30T10:15Znever https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-20162025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-trimestre-20162025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-lidera-consorcio-biomap2025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-recibe-opinion-positiva-del-chmp-para-okedir-como-tratamiento-esquizofrenia2021-12-21T12:30Znever https://rovi.es/es/content/enervit-nutrition-joint-venture-rovi-enervit-distribuira-productos-nutricionales-espana2025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-financieros-del-ano-20212022-02-01T15:56Znever https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-20152025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-recibe-aprobacion-comision-europea-para-okedir-como-tratamiento-esquizofrenia2022-03-08T17:04Znever https://rovi.es/es/content/presentacion-resultados-del-ejercicio-20152025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-moderna-amplian-su-colaboracion-largo-plazo-para-fabricacion-medicamentos-arnm-durante2022-02-16T08:06Znever https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-20212022-02-23T07:57Znever https://rovi.es/es/content/incorporacion-tecnologo-programa-idi-gracias-al-programa-emplea-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-periodo-9-meses-finalizado-30-septiembre-20152025-07-22T11:24Zyearly https://rovi.es/es/content/programa-apoyo-idi-empresarial2022-02-22T11:01Znever https://rovi.es/es/content/rovi-logra-neutralidad-carbono-20212022-03-04T09:17Znever https://rovi.es/es/content/presentacion-resultados-del-periodo-9-meses-finalizado-30-septiembre-20152025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-20152025-07-22T11:24Zyearly https://rovi.es/es/rovi-al-dia2022-04-01T07:43Znever https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-20152025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-financieros-del-primer-trimestre-20222022-04-05T12:21Znever https://rovi.es/es/content/notificacion-retirada-lote-no-000190a2022-04-08T17:06Znever https://rovi.es/es/content/rovi-presentara-resultados-positivos-sobre-risperidona-ismr-bemiparina-xii-congreso-eacpt2025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-20222022-05-11T05:51Znever https://rovi.es/es/content/rovi-anuncia-proxima-comercializacion-orvatez-espana2025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-alcanza-acuerdo-para-adquirir-activos-planta-fabricacion-san-sebastian-reyes2025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-20152025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-celebra-su-junta-general-accionistas-20222022-06-14T14:34Znever https://rovi.es/es/content/presentacion-resultados-del-primer-trimestre-20152025-07-22T11:24Zyearly https://rovi.es/es/content/claves-resultados-anuales-rovi2022-09-01T09:56Znever https://rovi.es/es/content/evita-reduce-compensa-rovi-logra-neutralidad-carbono-20212022-09-01T09:57Znever https://rovi.es/es/content/claves-resultados-del-t1-2022-rovi2022-06-24T12:22Znever https://rovi.es/es/content/resultados-financieros-del-primer-semestre-20222022-06-28T14:14Znever https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-20142025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-ejercicio-20142025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-20222022-07-27T06:22Znever https://rovi.es/es/content/banco-europeo-inversiones-rovi-impulsan-innovacion-sector-farmaceutico-espanol2022-07-19T09:56Znever https://rovi.es/es/content/rovi-lider-clasificacion-sostenibilidad-industria-farmaceutica-mundial-sustainalytics2022-08-01T07:59Znever https://rovi.es/es/content/rovi-reactiva-su-programa-voluntariado-corporativo2022-08-09T07:10Znever https://rovi.es/es/content/claves-resultados-del-primer-semestre-2022-rovi2022-09-14T07:00Znever https://rovi.es/es/content/rovi-anuncia-acuerdo-comercializacion-volutsa-espana2025-07-22T11:24Zyearly https://rovi.es/es/content/nace-glicopepton-biotech-para-producir-compuestos-alto-valor-tecnologico2022-10-04T11:14Znever https://rovi.es/es/content/resultados-financieros-nueve-primeros-meses-20222022-10-19T12:06Znever https://rovi.es/es/content/cmd-20222022-10-10T10:36Znever https://rovi.es/es/content/presidente-junta-andalucia-juan-manuel-moreno-visita-nueva-planta-rovi-escuzar-granada2022-10-24T10:56Znever https://rovi.es/es/content/rovi-anuncia-resultados-positivos-nuevo-ensayo-risperidona-ism2025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-nueve-primeros-meses-20222022-11-04T06:39Znever https://rovi.es/es/content/concesion-subvencion-para-actuaciones-eficiencia-energetica-pyme-gran-empresa-del-sector2022-11-14T16:33Znever https://rovi.es/es/content/presentacion-dia-del-mercado-capitales-20222022-11-23T06:14Znever https://rovi.es/es/content/nota-prensa-resultados-del-periodo-9-meses-finalizado-30-septiembre-20142025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-lanza-reto-para-desarrollar-soluciones-mejoren-tecnologias-inyectables-liberacion2022-12-05T09:43Znever https://rovi.es/es/content/concesion-subvencion-para-actuaciones-eficiencia-energetica-pyme-gran-empresa-del-sector-02022-12-05T09:42Znever https://rovi.es/es/content/resultados-financieros-del-ano-20222023-01-25T11:49Znever https://rovi.es/es/content/rovi-acoge-visita-del-ministro-sanidad-rumania-su-planta-alcala-henares2023-02-06T15:35Znever https://rovi.es/es/content/presentacion-resultados-del-periodo-9-meses-finalizado-30-septiembre-20142025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-20222023-02-21T07:11Znever https://rovi.es/es/content/rovi-informa-sobre-proceso-evaluacion-para-obtencion-autorizacion-comercializacion-estados2023-02-16T07:36Znever https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-20142025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-igualdad-como-compromiso-buen-gobierno2023-03-22T16:02Znever https://rovi.es/es/content/biosim-fortalece-su-representacion-nacional-con-incorporacion-laboratorios-farmaceuticos2023-03-21T12:11Znever https://rovi.es/es/content/claves-resultados-anuales-rovi-20222023-04-10T15:24Znever https://rovi.es/es/content/rovi-planta-bosque-2000-arboles-sierra-madrid2023-03-27T09:26Znever https://rovi.es/es/content/creada-catedra-para-estudiar-impacto-psicologico-digitalizacion-beneficios-tecnologia-para2023-04-12T07:27Znever https://rovi.es/es/content/salud-seguridad-centro-nuestras-operaciones2023-04-19T14:53Znever https://rovi.es/es/content/resultados-financieros-del-primer-trimestre-20242024-04-04T15:04Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-20142025-07-22T11:24Zyearly https://rovi.es/es/sostenibilidad2026-03-03T16:47Zmonthly https://rovi.es/es/sostenibilidad/gobierno-responsable2025-07-16T08:16Zyearly https://rovi.es/es/sostenibilidad/compromiso-personas2026-02-11T12:51Zmonthly https://rovi.es/es/sostenibilidad/compromiso-ambiental2026-03-16T15:10Zmonthly https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-20142025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-inicia-desarrollo-clinico-nueva-formulacion-trimestral-letrozol-letrozol-lebe2023-04-25T06:29Znever https://rovi.es/es/content/rovi-lidera-consorcio-bioelast-aprobado-convocatoria-2021-proyectos-colaboracion-publico2025-03-19T11:01Zyearly https://rovi.es/es/content/concesion-ayuda-parcialmente-reembolsable-para-evaluacion-toxicidad-risperidona-ismr2023-05-08T11:12Znever https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-20232023-05-10T06:00Znever https://rovi.es/es/content/presentacion-resultados-del-primer-trimestre-20142025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-20132025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-ejercicio-20132025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-anuncia-comercializacion-exclusiva-medikinet-medicebran-espana2025-07-22T11:24Zyearly https://rovi.es/es/content/conoce-laboratorios-rovi-claves-su-proyecto-empresarial2023-05-25T07:21Znever https://rovi.es/es/content/rovi-anuncia-acuerdo-comercializacion-hirobriz-breezhaler-ulunar-breezhaler-espana2025-07-22T11:24Zyearly https://rovi.es/es/canal-etico2024-08-02T10:48Zyearly https://rovi.es/es/content/rovi-celebra-su-junta-general-accionistas-20232023-06-14T12:51Znever https://rovi.es/es/content/rovi-ratifica-su-compromiso-como-empresa-medioambientalmente-sostenible2023-06-22T07:22Znever https://rovi.es/es/content/resultados-financieros-del-primer-semestre-20232023-06-29T07:44Znever https://rovi.es/es/content/laboratorios-rovi-contribuye-activamente-al-desarrollo-sostenible2023-07-13T08:35Znever https://rovi.es/es/content/nota-prensa-resultados-del-periodo-9-meses-finalizado-30-septiembre-20132025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-20232023-07-26T06:31Znever https://rovi.es/es/content/rovi-informa-sobre-proceso-evaluacion-para-obtencion-autorizacion-comercializacion-estados-02023-07-28T07:30Znever https://rovi.es/es/content/presentacion-resultados-del-periodo-9-meses-finalizado-30-septiembre-20132025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-mantiene-primera-posicion-ranking-mundial-riesgos-esg-sustainalytics-por-segundo-ano2023-08-04T06:47Znever https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-20132025-07-22T11:24Zyearly https://rovi.es/es/content/laboratorios-rovi-impulsamos-crecimiento-sostenible-hacia-ano-2025-con-plan-director-esg2023-08-30T08:23Znever https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-20132025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-financieros-nueve-primeros-meses-20232023-09-27T10:41Znever https://rovi.es/es/content/rovi-ejercita-opcion-compra-sobre-rhodogil2025-07-22T11:24Zyearly https://rovi.es/es/content/lucha-contra-cambio-climatico-uno-principios-rige-operacion-laboratorios-rovi2023-10-31T08:05Znever https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-20132025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-trimestre-20132025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-nueve-primeros-meses-20232023-11-08T06:40Znever https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-20122025-07-22T11:24Zyearly https://rovi.es/es/content/seis-pilares-politica-empleo-laboratorios-rovi2023-12-21T14:48Znever https://rovi.es/es/content/laboratorios-rovi-refuerza-2023-sus-actividades-voluntariado2024-01-15T08:52Znever https://rovi.es/es/content/presentacion-resultados-del-ejercicio-20122025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-financieros-del-ano-20232024-01-30T08:17Znever https://rovi.es/es/content/declaracion-intermedia-300920122025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-periodo-9-meses-finalizado-30-septiembre-20122025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-20232024-02-27T08:54Znever https://rovi.es/es/content/rovi-obtiene-aprobacion-fda-para-su-planta-inyectables2025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-insud-pharma-e-innvierte-cdti-crean-sociedad-para-investigacion-desarrollo-terapias2024-03-12T16:22Znever https://rovi.es/es/content/rovi-ucb-ponen-fin-su-relacion-comercial-sobre-cimzia2025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-recibe-aprobacion-fda-para-risvanr-como-tratamiento-esquizofrenia2024-04-02T05:10Znever https://rovi.es/es/content/resultados-del-primer-semestre-20122025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-lidera-consorcio-hera-aprobado-convocatoria-2022-proyectos-colaboracion-publico-privada2024-04-23T07:31Zyearly https://rovi.es/es/content/rovi-anuncia-acuerdo-para-fabricacion-jeringas-precargadas2024-04-25T07:54Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-20122025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-tres-primeros-meses-20242024-05-08T05:39Zyearly https://rovi.es/es/content/declaracion-intermedia-310320122025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-primer-trimestre-20122025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-20112025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-ejercicio-20112025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-financieros-del-primer-semestre-20242024-05-24T11:58Zyearly https://rovi.es/es/content/rovi-finaliza-su-nueva-planta-escuzar-e-incorpora-linea-produccion-heparina-sodica2024-06-20T07:25Zyearly https://rovi.es/es/content/corlentorr-obtiene-aprobacion-para-su-uso-insuficiencia-cardiaca2025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-preve-ventas-potenciales-risperidona-ismr-entre-200-300-millones-euros-nivel-global2024-06-24T08:15Zyearly https://rovi.es/es/content/laboratorios-rovi-como-empresa-responsable-comprometida-con-medio-ambiente2024-06-28T08:12Zyearly https://rovi.es/es/content/rovi-invierte-60-millones-euros-para-ampliar-315-por-ciento-capacidad-produccion-planta-san2024-07-11T11:46Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-20242024-07-31T05:46Zyearly https://rovi.es/es/_reglamento-interno-de-conducta-relativo-a-la-operativa-en-el-mercado-de-valores2017-08-01T16:34Znever https://rovi.es/es/content/compromiso-con-generacion-empleo-laboratorios-rovi2024-09-06T11:35Zyearly https://rovi.es/es/content/resultados-financieros-nueve-primeros-meses-20242024-11-07T08:36Zyearly https://rovi.es/es/content/rovi-finaliza-revision-estrategica-su-negocio-cdmo2024-10-24T05:54Zyearly https://rovi.es/es/content/declaracion-intermedia-300920112025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-nueve-primeros-meses-20242024-11-07T07:28Zyearly https://rovi.es/es/content/presentacion-resultados-periodo-9-meses-finalizado-30-septiembre-20112025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-financieros-del-ano-20242025-01-15T16:07Zyearly https://rovi.es/es/content/capital-market-day-20252025-01-16T13:59Zyearly https://rovi.es/es/content/programa-voluntariado-corporativo-ha-reforzado-compromiso-social-rovi-20242025-01-16T15:37Zyearly https://rovi.es/es/content/resultados-del-analisis-final-del-estudio-clinico-fase-ii-abel2025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-20242025-02-25T07:15Zyearly https://rovi.es/es/content/alentia-biotech-planea-construccion-centro-nacional-produccion-para-abastecimiento-vacunas2025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-dia-del-mercado-capitales-20252025-03-25T07:44Zyearly https://rovi.es/es/content/resultados-financieros-del-primer-trimestre-20252025-03-27T15:40Zyearly https://rovi.es/es/content/nuevos-resultados-del-estudio-shift-pacientes-con-insuficiencia-cardiaca-con-corlentor2025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-tres-primeros-meses-20252025-05-08T06:03Zyearly https://rovi.es/es/content/resultados-del-primer-semestre-20112025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-primer-semestre-20112025-07-22T11:24Zyearly https://rovi.es/es/content/declaracion-intermedia-310320112025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-primer-trimestre-20112025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-financieros-del-primer-semestre-20252025-06-13T11:12Zyearly https://rovi.es/es/content/rovi-celebra-su-junta-general-accionistas-20252025-06-18T13:08Zyearly https://rovi.es/es/content/resultados-del-ejercicio-20102025-07-22T11:24Zyearly https://rovi.es/es/content/transparencia-trazabilidad-informacion-no-financiera-asi-funciona-sciinf-rovi2025-06-20T12:58Zyearly https://rovi.es/es/content/resolucion-definitiva-concesion-subvencion-363-millones-euros-para-proyecto-laisolid-rovi2025-07-10T12:21Zyearly https://rovi.es/es/content/rovi-recibira-363-millones-euros-para-investigacion-farmacos-liberacion-prolongada-nuevas2025-07-10T13:52Zyearly https://rovi.es/es/content/rovi-firma-contrato-con-farmalider-para-fabricacion-formas-orales2025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-20252025-07-24T06:04Zyearly https://rovi.es/es/content/decisiones-sostenibles-plenamente-integradas-modelo-gestion-rovi2025-09-03T09:45Zyearly https://rovi.es/es/content/resultados-financieros-nueve-primeros-meses-20252025-09-04T14:53Zyearly https://rovi.es/es/content/rovi-anuncia-adquisicion-planta-fabricacion-productos-farmaceuticos-inyectables-phoenix2025-10-02T15:02Zyearly https://rovi.es/es/content/rovi-anuncia-adquisicion-planta-fabricacion-productos-farmaceuticos-inyectables-phoenix-02025-09-30T09:50Zyearly https://rovi.es/es/content/comercializacion-absorcol-vytorin-primera-cinco-licencias-msd2025-07-22T11:24Zyearly https://rovi.es/es/content/llega-rois-nueva-imagen-para-empresa-cdmo-expansion2025-10-03T09:46Zyearly https://rovi.es/es/content/rovi-anuncia-colaboracion-con-roche-para-fabricacion-nuevo-medicamento-desarrollo2025-10-21T13:49Zyearly https://rovi.es/es/content/resultados-del-estudio-fase-i-bemiparina-oral-basada-tecnologia-ocap2025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-nueve-primeros-meses-20252025-11-06T12:17Zyearly https://rovi.es/es/content/rovi-hace-publico-comunicado-prensa-relativo-firma-del-acuerdo-definitivo-colaboracion-con2025-11-18T07:26Zyearly https://rovi.es/es/content/resultados-financieros-del-ano-20252026-01-20T09:23Zyearly https://rovi.es/es/content/nota-prensa-resultados-20252026-02-25T07:34Zmonthly https://rovi.es/es/content/rovi-refuerza-su-impacto-social-2025-traves-del-voluntariado-corporativo2026-03-06T13:09Zmonthly https://rovi.es/es/content/resultados-financieros-del-primer-trimestre-20262026-03-13T09:45Zmonthly https://rovi.es/es/content/rovi-informa-del-cierre-del-contrato-compraventa-activos-suscrito-septiembre-2025-relativo2026-04-01T07:40Zdaily https://rovi.es/es/content/el-biosimilar-de-enoxaparina-una-gran-oportunidad-para-rovi-02017-07-26T12:50Znever https://rovi.es/es/content/presentación-sobre-el-biosimilar-de-enoxaparina-de-rovi-12017-07-26T12:50Znever https://rovi.es/es/home-22017-06-27T12:26Znever https://rovi.es/es/content/rovi-finaliza-con-resultado-positivo-el-procedimiento-descentralizado-para-el-registro-de-22017-07-26T12:51Znever https://rovi.es/es/content/nota-de-prensa-de-resultados-del-ejercicio-2016-02017-09-20T13:29Znever https://rovi.es/es/content/presentación-resultados-del-ejercicio-2016-02017-09-20T13:29Znever https://rovi.es/es/content/incorporación-de-dos-doctores-al-área-de-id-dentro-del-programa-torres-quevedo-12017-09-14T15:57Znever https://rovi.es/es/home-32017-06-27T12:26Znever https://rovi.es/es/content/page2017-06-27T12:22Znever https://rovi.es/es/fullwidth/pricing-table2017-06-27T12:21Znever https://rovi.es/es/content/features2017-06-27T12:22Znever https://rovi.es/es/fullwidth/accordion2017-06-27T12:21Znever https://rovi.es/es/content/carousel2017-06-27T12:22Znever https://rovi.es/es/content/alert-panel2017-06-27T12:21Znever https://rovi.es/es/fullwidth/animate2017-06-27T12:21Znever https://rovi.es/es/fullwidth/animated-graphs2017-06-27T12:20Znever https://rovi.es/es/content/enervit-nutrition-joint-venture-rovi-enervit-distribuira-productos-nutricionales-espana-02025-07-22T11:24Zyearly https://rovi.es/es/content/dropcaps2017-06-27T12:21Znever https://rovi.es/es/fullwidth/icon-boxes2017-06-27T12:16Znever https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-2015-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-periodo-9-meses-finalizado-30-septiembre-2016-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-2016-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-2016-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-ejercicio-2015-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-periodo-9-meses-finalizado-30-septiembre-2016-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-2016-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-trimestre-2016-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-anuncia-acuerdo-comercializacion-mysimba-espana-02025-07-22T11:24Zyearly https://rovi.es/es/content/list-icon2017-06-27T12:21Znever https://rovi.es/es/content/rovi-anuncia-acuerdo-comercializacion-neparvis-espana-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-lidera-consorcio-biomap-02025-07-22T11:24Zyearly https://rovi.es/es/content/incorporacion-tecnologo-programa-idi-gracias-al-programa-emplea-12025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-2014-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-periodo-9-meses-finalizado-30-septiembre-2015-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-2015-02025-07-22T11:24Zyearly https://rovi.es/es/fullwidth/tabs2017-06-27T12:13Znever https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-2015-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-ejercicio-2014-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-periodo-9-meses-finalizado-30-septiembre-2015-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-2015-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-trimestre-2015-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-alcanza-acuerdo-para-adquirir-activos-planta-fabricacion-san-sebastian-reyes-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-anuncia-acuerdo-comercializacion-volutsa-espana-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-anuncia-proxima-comercializacion-orvatez-espana-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-presentara-resultados-positivos-sobre-risperidona-ismr-bemiparina-xii-congreso-eacpt-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-2013-02025-07-22T11:24Zyearly https://rovi.es/es/fullwidth/button2017-06-27T12:20Znever https://rovi.es/es/content/nota-prensa-resultados-del-periodo-9-meses-finalizado-30-septiembre-2014-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-2014-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-2014-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-ejercicio-2013-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-periodo-9-meses-finalizado-30-septiembre-2014-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-2014-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-trimestre-2014-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-anuncia-resultados-positivos-nuevo-ensayo-risperidona-ism-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-2012-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-periodo-9-meses-finalizado-30-septiembre-2013-02025-07-22T11:24Zyearly https://rovi.es/es/fullwidth/column-content2017-06-27T12:13Znever https://rovi.es/es/content/nota-prensa-resultados-del-primer-semestre-2013-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-primer-trimestre-2013-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-ejercicio-2012-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-periodo-9-meses-finalizado-30-septiembre-2013-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-2013-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-trimestre-2013-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-anuncia-acuerdo-comercializacion-hirobriz-breezhaler-ulunar-breezhaler-espana-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-anuncia-comercializacion-exclusiva-medikinet-medicebran-espana-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-ejercita-opcion-compra-sobre-rhodogil-02025-07-22T11:24Zyearly https://rovi.es/es/content/corlentorr-obtiene-aprobacion-para-su-uso-insuficiencia-cardiaca-02025-07-22T11:24Zyearly https://rovi.es/es/fullwidth/typography2017-06-27T12:17Znever https://rovi.es/es/content/declaracion-intermedia-31032012-02025-07-22T11:24Zyearly https://rovi.es/es/content/declaracion-intermedia-30092012-02025-07-22T11:24Zyearly https://rovi.es/es/content/nota-prensa-resultados-del-ejercicio-2011-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-ejercicio-2011-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-del-primer-semestre-2012-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-periodo-9-meses-finalizado-30-septiembre-2012-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-primer-trimestre-2012-02025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-del-primer-semestre-2012-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-obtiene-aprobacion-fda-para-su-planta-inyectables-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-ucb-ponen-fin-su-relacion-comercial-sobre-cimzia-02025-07-22T11:24Zyearly https://rovi.es/es/content/alentia-biotech-planea-construccion-centro-nacional-produccion-para-abastecimiento-vacunas-02025-07-22T11:24Zyearly https://rovi.es/es/content/comercializacion-absorcol-vytorin-primera-cinco-licencias-msd-02025-07-22T11:24Zyearly https://rovi.es/es/content/declaracion-intermedia-30092011-02025-07-22T11:24Zyearly https://rovi.es/es/content/declaracion-intermedia-31032011-02025-07-22T11:24Zyearly https://rovi.es/es/content/nuevos-resultados-del-estudio-shift-pacientes-con-insuficiencia-cardiaca-con-corlentor-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-periodo-9-meses-finalizado-30-septiembre-2011-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-primer-semestre-2011-02025-07-22T11:24Zyearly https://rovi.es/es/content/presentacion-resultados-primer-trimestre-2011-02025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-del-analisis-final-del-estudio-clinico-fase-ii-abel-02025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-del-ejercicio-2010-02025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-del-estudio-fase-i-bemiparina-oral-basada-tecnologia-ocap-02025-07-22T11:24Zyearly https://rovi.es/es/content/resultados-del-primer-semestre-2011-02025-07-22T11:24Zyearly https://rovi.es/es/content/rovi-firma-contrato-con-farmalider-para-fabricacion-formas-orales-02025-07-22T11:24Zyearly https://rovi.es/es/home-12017-06-27T12:16Znever https://rovi.es/es/home2026-03-03T16:52Zmonthly1.0 https://rovi.es/es/content/home-v22017-06-27T12:16Znever https://rovi.es/es/content/element2017-06-27T12:14Znever https://rovi.es/es/content/home-v32017-06-27T12:15Znever https://rovi.es/es/content/home-42017-06-27T12:13Znever https://rovi.es/en/content/release-full-year-2010-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/release-first-quarter-2011-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/release-first-half-2011-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/release-financial-results-nine-month-period-ended-30-september-20112021-10-10T10:51Znever https://rovi.es/en/content/santander-spanish-small-caps-seminar2021-10-10T10:51Znever https://rovi.es/en/content/release-full-year-2011-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/crédit-suisse-global-healthcare-conference2021-10-10T10:51Znever https://rovi.es/en/content/january-march-2012-results2021-10-10T10:51Znever https://rovi.es/en/content/viii-medcap-forum2021-10-10T10:51Znever https://rovi.es/en/content/viii-medcap-forum-02021-10-10T10:51Znever https://rovi.es/en/content/release-first-half-2012-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/morgan-stanley-global-healthcare-conference2021-10-10T10:51Znever https://rovi.es/en/content/ubs-global-life-sciences-conference2021-10-10T10:51Znever https://rovi.es/en/content/banesto-spanish-small-caps-seminar2021-10-10T10:51Znever https://rovi.es/en/content/january-september-2012-results2021-10-10T10:51Znever https://rovi.es/en/content/jefferies-global-healthcare-conference2021-10-10T10:51Znever https://rovi.es/en/content/santander-spanish-small-caps-seminar-02021-10-10T10:51Znever https://rovi.es/en/content/full-year-2012-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/crédit-suisse-global-healthcare-conference-02021-10-10T10:51Znever https://rovi.es/en/content/january-march-2013-results2021-10-10T10:51Znever https://rovi.es/en/content/banesto-spanish-small-caps-seminar-02021-10-10T10:51Znever https://rovi.es/en/content/ubs-global-healthcare-conference2021-10-10T10:51Znever https://rovi.es/en/content/ix-medcap-forum2021-10-10T10:51Znever https://rovi.es/en/content/2013-first-half-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/morgan-stanley-global-healthcare-conference-02021-10-10T10:51Znever https://rovi.es/en/content/4th-bbva-iberian-conference2021-10-10T10:51Znever https://rovi.es/en/content/cheuvreux-2013-autumn-conference2021-10-10T10:51Znever https://rovi.es/en/content/january-september-2013-results2021-10-10T10:51Znever https://rovi.es/en/content/santander-iberian-conference-madrid2021-10-10T10:51Znever https://rovi.es/en/content/full-year-2013-financial-results-20132021-10-10T10:51Znever https://rovi.es/en/content/credit-suisse-healthcare-conference-london2021-10-10T10:51Znever https://rovi.es/en/content/january-march-2014-results2021-10-10T10:51Znever https://rovi.es/en/content/ubs-healthcare-conference-new-york2021-10-10T10:51Znever https://rovi.es/en/content/foro-medcap-bolsa-de-madrid2021-10-10T10:51Znever https://rovi.es/en/content/foro-medcap-bolsa-de-madrid-02021-10-10T10:51Znever https://rovi.es/en/content/annual-general-meeting2021-10-10T10:51Znever https://rovi.es/en/content/3rd-spanish-smallmid-cap-conference-new-york2021-10-10T10:51Znever https://rovi.es/en/content/january-june-2014-results2021-10-10T10:51Znever https://rovi.es/en/content/morgan-stanley-healthcare-conference-new-york2021-10-10T10:51Znever https://rovi.es/en/content/bbva-iberian-day-london2021-10-10T10:51Znever https://rovi.es/en/content/kepler-cheuvreux-autumn-conference-paris2021-10-10T10:51Znever https://rovi.es/en/content/january-september-2014-results2021-10-10T10:51Znever https://rovi.es/en/content/jefferies-2014-global-healthcare-conference-london2021-10-10T10:51Znever https://rovi.es/en/content/jefferies-2014-global-healthcare-conference-london-02021-10-10T10:51Znever https://rovi.es/en/content/full-year-2014-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/credit-suisse-one-one-healthcare-conference-london2021-10-10T10:51Znever https://rovi.es/en/content/credit-suisse-one-one-healthcare-conference-london-02021-10-10T10:51Znever https://rovi.es/en/content/january-march-2015-results2021-10-10T10:51Znever https://rovi.es/en/content/ubs-global-healthcare-conference-new-york2021-10-10T10:51Znever https://rovi.es/en/content/ubs-global-healthcare-conference-new-york-02021-10-10T10:51Znever https://rovi.es/en/content/ubs-global-healthcare-conference-new-york-12021-10-10T10:51Znever https://rovi.es/en/content/first-half-2015-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/jefferies-global-healthcare-conference-02021-10-10T10:51Znever https://rovi.es/en/content/full-year-2015-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/credit-suisse-global-healthcare-conference-12021-10-10T10:51Znever https://rovi.es/en/content/credit-suisse-global-healthcare-conference-22021-10-10T10:51Znever https://rovi.es/en/content/first-half-2016-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/bbva-conference-london2021-10-10T10:51Znever https://rovi.es/en/content/kepler-cheuvreux-autumn-conference-paris-02021-10-10T10:51Znever https://rovi.es/en/content/january-september-2016-results2021-10-10T10:51Znever https://rovi.es/en/content/full-year-2016-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/first-quarter-2017-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/rovi-general-shareholders-meeting-20172021-10-10T10:51Znever https://rovi.es/en/content/pago-de-dividendos2021-10-10T10:51Znever https://rovi.es/en/content/first-half-2017-financial-results2021-10-10T10:51Znever https://rovi.es/en/calculadora2021-12-30T10:40Znever https://rovi.es/en/content/2017-first-half-results-presentation2021-10-10T10:53Znever https://rovi.es/en/content/first-half-2017-results-press-release-02021-10-10T10:53Znever https://rovi.es/en/medios-contacto2026-01-27T12:05Zyearly https://rovi.es/en/últimos-resultados2025-07-22T11:23Zyearly https://rovi.es/en/content/2013-first-quarter-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/first-half-2017-results-press-release-12025-07-22T11:24Zyearly https://rovi.es/en/content/2017-first-half-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/9m-2017-results-press-release2021-10-10T10:53Znever https://rovi.es/en/content/9m-2017-results-presentation2021-10-10T10:53Znever https://rovi.es/en/content/presentation-risperidone-ism®-project-02017-11-29T09:50Znever https://rovi.es/en/content/presentation-results-january-september-20172017-11-29T09:49Znever https://rovi.es/en/content/january-september-2017-results-press-release2017-12-13T10:02Znever https://rovi.es/en/content/loan-granted-european-investment-bank-rovi2017-12-21T17:02Znever https://rovi.es/en/content/rovi-and-eib-agreement2021-10-10T10:53Znever https://rovi.es/en/content/full-year-2017-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/2017-results-press-release2021-11-02T17:20Znever https://rovi.es/en/content/2017-results-press-release-02018-02-20T08:30Znever https://rovi.es/en/content/2017-results-presentation2018-02-20T08:30Znever https://rovi.es/en/content/2017-results-presentation-02021-11-02T17:20Znever https://rovi.es/en/content/doriar-presentation2021-11-08T10:57Znever https://rovi.es/en/content/rovi-announces-agreement-hikma-distribute-and-market-its-enoxaparin-biosimilar2018-04-24T07:52Znever https://rovi.es/en/content/rovi-announces-agreement-hikma-distribute-and-market-its-enoxaparin-biosimilar-02021-10-10T10:53Znever https://rovi.es/en/content/test2017-06-27T14:14Znever https://rovi.es/en/content/2018-first-quarter-results-press-release2018-04-25T06:29Znever https://rovi.es/en/content/2018-first-quarter-results-press-release-02021-11-02T17:17Znever https://rovi.es/en/laboratorio-de-historia2023-07-14T08:54Znever https://rovi.es/en/content/2018-first-quarter-results-presentation2021-10-10T10:53Znever https://rovi.es/en/estructura-societaria2025-05-05T11:58Zyearly https://rovi.es/en/unidades-de-negocio2023-10-19T08:53Znever https://rovi.es/en/expansión-internacional2023-11-10T11:01Znever https://rovi.es/en/estrategia2024-08-07T10:33Zyearly https://rovi.es/en/licencias2017-11-29T16:38Znever https://rovi.es/en/informacion-de-contacto2022-11-15T15:38Znever https://rovi.es/en/trabaja-con-nosotros2024-10-01T15:08Zyearly https://rovi.es/en/capital-increased2025-07-22T11:22Zyearly https://rovi.es/en/medios2017-09-21T10:12Znever https://rovi.es/en/content/rovi-announces-agreement-sandoz-distribute-and-market-its-enoxaparin-biosimilar2018-06-12T10:16Znever https://rovi.es/en/content/rovi-announces-agreement-sandoz-distribute-and-market-its-enoxaparin-biosimilar-02021-11-02T17:21Znever https://rovi.es/en/content/awarded-grant-co-funded-european-unions-european-regional-development-fund-feder2018-06-20T12:01Znever https://rovi.es/en/faqs2022-06-29T14:24Znever https://rovi.es/en/content/first-half-2018-financial-results2021-10-10T10:51Znever https://rovi.es/en/noticias2022-06-29T14:25Znever https://rovi.es/en/content/2018-first-quarter-results-press-release-12018-07-26T06:00Znever https://rovi.es/en/content/2018-first-half-results-press-release2021-11-02T17:14Znever https://rovi.es/en/content/2018-first-half-results-presentation2021-11-08T10:59Znever https://rovi.es/en/content/enervit-exercises-purchase-option-1-enervit-nutrition-joint-venture-between-rovi-and-enervit2018-07-27T06:23Znever https://rovi.es/en/content/enervit-exercises-purchase-option-1-enervit-nutrition-joint-venture-between-rovi-and-02021-10-10T10:53Znever https://rovi.es/en/content/rovi-has-commenced-marketing-its-enoxaparin-biosimilar-spain2018-09-19T10:34Znever https://rovi.es/en/content/rovi-has-commenced-marketing-its-enoxaparin-biosimilar-spain-02021-11-02T17:10Znever https://rovi.es/en/content/rovi-announces-agreement-biogaran-marketing-its-enoxaparin-biosimilar-france2018-09-20T07:14Znever https://rovi.es/en/content/rovi-announces-agreement-biogaran-marketing-its-enoxaparin-biosimilar-france-02021-11-02T17:10Znever https://rovi.es/en/content/9m-2018-results-press-release2021-11-02T17:09Znever https://rovi.es/en/content/9m-2018-results-presentation2021-11-02T17:09Znever https://rovi.es/en/content/rovi-acquires-falithrom®-german-market2019-01-09T07:14Znever https://rovi.es/en/content/rovi-acquires-falithromr-german-market2021-11-10T16:39Znever https://rovi.es/en/content/full-year-2018-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/awarded-grant-co-funded-european-unions-european-regional-development-fund-feder-02021-11-02T17:19Znever https://rovi.es/en/content/rovi-acquires-rights-dexchlorpheniramine-maleate-spanish-and-french-markets2019-02-15T07:52Znever https://rovi.es/en/cobertura-por-analistas2021-12-30T10:30Znever https://rovi.es/en/content/rovi-acquires-rights-dexchlorpheniramine-maleate-spanish-and-french-markets-02021-11-10T16:39Znever https://rovi.es/en/content/full-year-2018-results-press-release2019-02-26T07:06Znever https://rovi.es/en/información-general-de-la-sociedad2021-12-30T10:28Znever https://rovi.es/en/content/rovi-reports-operating-revenue-growth-10-underpinned-behaviour-its-low-molecular-weight2021-11-10T16:39Znever https://rovi.es/en/content/2018-full-year-results-presentation2021-11-26T10:05Znever https://rovi.es/en/cauces-de-comunicación-con-la-sociedad2021-12-30T10:28Znever https://rovi.es/en/la-acción-y-su-capital-social2021-12-30T10:28Znever https://rovi.es/en/content/positive-topline-results-phase-3-study-doria®-patients-schizophrenia2019-03-19T06:55Znever https://rovi.es/en/content/rovi-announces-positive-topline-results-phase-3-study-doriar-patients-schizophrenia2021-11-10T15:52Znever https://rovi.es/en/content/positive-topline-results-phase-3-study-doria®-patients-schizophrenia-12021-10-10T10:51Znever https://rovi.es/en/dividendos2021-12-30T10:31Znever https://rovi.es/en/ofertas-públicas-de-venta-y-admisión-de-valores2021-12-30T10:31Znever https://rovi.es/en/ofertas-públicas-de-adquisición-de-valores-opa2021-12-30T10:31Znever https://rovi.es/en/content/first-quarter-2019-results-press-release2019-05-08T06:51Znever https://rovi.es/en/content/rovi-reports-operating-revenue-growth-8-underpinned-outstanding-low-molecular-weight-heparin2021-11-10T15:48Znever https://rovi.es/en/content/first-quarter-2019-results-presentation-02022-01-13T09:49Znever https://rovi.es/en/pactos-parasociales2021-12-30T10:30Znever https://rovi.es/en/i-d2025-08-28T11:04Zyearly https://rovi.es/en/pipeline2017-11-29T16:44Znever https://rovi.es/en/ism2021-07-23T13:11Znever https://rovi.es/en/productos-hospitalarios2023-12-19T10:03Znever https://rovi.es/en/content/lópez-belmonte-family-increase-their-interest-rovi-6312019-05-27T16:15Znever https://rovi.es/en/content/lopez-belmonte-family-increase-their-interest-rovi-631-02021-11-10T15:41Znever https://rovi.es/en/glicómica2025-07-22T11:23Zyearly https://rovi.es/en/content/first-half-2019-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/rovi-announces-completion-clinical-trial-program-will-support-application-marketing2019-07-05T06:24Znever https://rovi.es/en/tecnología-multicapas-de-aplicación-catéteres-uretrales2025-07-22T11:23Zyearly https://rovi.es/en/content/rovi-announces-completion-clinical-trial-program-will-support-application-marketing-02021-11-10T15:35Znever https://rovi.es/en/fabricación2025-08-08T16:43Zyearly https://rovi.es/en/content/first-half-2019-results-press-release2019-07-30T05:56Znever https://rovi.es/en/fabricación-propia2025-08-08T17:22Zyearly https://rovi.es/en/content/rovi-increases-its-operating-revenue-21-and-ebitda-992021-11-10T15:47Znever https://rovi.es/en/fabricación-a-terceros2025-08-28T10:58Zyearly https://rovi.es/en/content/first-half-2019-results-presentation2021-11-02T16:55Znever https://rovi.es/en/content/rovi-announces-construction-second-heparin-plant-granada2019-09-05T10:14Znever https://rovi.es/en/productos-de-prescripción2025-10-31T07:31Zyearly https://rovi.es/en/content/rovi-announces-construction-second-heparin-plant-granada-02021-11-10T14:44Znever https://rovi.es/en/content/january-september-2019-results2021-10-10T10:51Znever https://rovi.es/en/rsc2025-07-22T11:23Zyearly https://rovi.es/en/content/first-nine-months-2019-results-press-release2019-11-07T06:52Znever https://rovi.es/en/home2026-03-03T16:53Zmonthly1.0 https://rovi.es/en/content/rovi-reports-operating-revenue-growth-24-and-ebitda-growth-832021-11-10T15:47Znever https://rovi.es/en/rovi2017-09-27T17:53Znever https://rovi.es/en/content/2019-investor-day-presentation-02021-11-01T11:23Znever https://rovi.es/en/misión-visión-y-valores2025-07-22T11:23Zyearly https://rovi.es/en/content/financial-results-nine-month-period-2019-video-02021-10-10T10:53Znever https://rovi.es/en/relaciones-con-los-grupos-de-interés2025-07-22T11:23Zyearly https://rovi.es/en/content/rovi-announces-commencement-assessment-process-obtain-marketing-authorisation-doria®2020-01-31T07:24Znever https://rovi.es/en/content/rovi-announces-commencement-assessment-process-obtain-marketing-authorisation-doriar2021-11-16T06:49Znever https://rovi.es/en/content/full-year-2019-financial-results2021-10-10T10:51Znever https://rovi.es/en/productos2023-09-14T17:20Znever https://rovi.es/en/compromiso-con-la-sociedad2025-07-22T11:23Zyearly https://rovi.es/en/content/full-year-2019-results-press-release2020-02-26T07:30Znever https://rovi.es/en/compromiso-con-el-medio-ambiente2025-07-22T11:23Zyearly https://rovi.es/en/contacto2021-12-30T10:01Znever https://rovi.es/en/content/rovi-reports-operating-revenue-growth-26-and-ebitda-growth-1062021-11-16T06:47Znever https://rovi.es/en/content/full-year-2019-results-presentation2021-11-02T16:39Znever https://rovi.es/en/compromiso-con-los-empleados2025-07-22T11:23Zyearly https://rovi.es/en/content/press-release-grant-research-project2021-10-10T10:53Znever https://rovi.es/en/espacio-del-inversor2021-12-30T10:06Znever https://rovi.es/en/content/rovi-informs-impact-covid-19-company’s-activities2020-04-02T15:53Znever https://rovi.es/en/content/rovi-informs-impact-covid-19-companys-activities2021-11-16T06:42Znever https://rovi.es/en/gobierno-corporativo2021-12-30T10:41Znever https://rovi.es/en/content/rovi-signs-co-operation-agreement-clinical-trial-study-efficacy-and-safety-bemiparin2020-04-14T06:13Znever https://rovi.es/en/content/rovi-signs-co-operation-agreement-clinical-trial-study-efficacy-and-safety-bemiparin-02021-11-16T06:39Znever https://rovi.es/en/content/january-march-2020-results2021-10-10T10:51Znever https://rovi.es/en/detalle-noticia2025-07-22T11:23Zyearly https://rovi.es/en/content/first-quarter-2020-results-press-release2020-05-13T06:08Znever https://rovi.es/en/accionistas-e-inversores2025-07-22T11:23Zyearly https://rovi.es/en/content/rovi-reports-operating-revenue-growth-23-and-ebitda-growth-682021-11-16T06:38Znever https://rovi.es/en/content/first-quarter-2020-results-presentation-02021-11-02T16:37Znever https://rovi.es/en/información-económica-financiera2025-07-22T11:23Zyearly https://rovi.es/en/foro-de-accionistas2021-12-30T10:44Znever https://rovi.es/en/content/first-half-2020-financial-results2021-10-10T10:51Znever https://rovi.es/en/content/moderna-and-rovi-announce-collaboration-outside-united-states-fill-finish-manufacturing2020-07-09T11:58Znever https://rovi.es/en/content/rovi-and-moderna-announce-collaboration-outside-united-states-fill-finish-manufacturing2021-11-16T06:35Znever https://rovi.es/en/junta-general-de-accionistas-ejercicio-del-derecho-de-información2021-12-30T10:42Znever https://rovi.es/en/estatutos2025-07-22T11:23Zyearly https://rovi.es/en/content/first-half-2020-results-press-release2020-07-27T05:53Znever https://rovi.es/en/convocatoria-y-orden-del-día-de-la-junta2021-12-30T10:42Znever https://rovi.es/en/content/rovi-reports-operating-revenue-growth-8-and-net-profit-growth-832021-11-15T18:19Znever https://rovi.es/en/content/first-half-2020-results-presentation2021-11-02T16:35Znever https://rovi.es/en/participaciones-significativas-y-autocartera2025-07-22T11:23Zyearly https://rovi.es/en/solicitudes-de-información-o-aclaraciones-solicitadas-por-los-accionistas2021-12-30T10:42Znever https://rovi.es/en/delegaciones-de-voto2021-12-30T10:43Znever https://rovi.es/en/información-pública-periódica2025-07-22T11:23Zyearly https://rovi.es/en/content/rovi-rating-esg-20202021-10-10T10:53Znever https://rovi.es/en/voto-distancia-en-las-juntas-generales2021-12-30T10:43Znever https://rovi.es/en/content/january-september-2020-results2021-10-10T10:51Znever https://rovi.es/en/content/rovi-holds-its-2020-general-shareholders-meeting2021-11-15T18:13Znever https://rovi.es/en/información-remitida-con-el-carácter-de-pública-otros-organismos-reguladores-en-el-supuesto2025-07-22T11:23Zyearly https://rovi.es/en/rating2025-07-22T11:23Zyearly https://rovi.es/en/content/first-nine-months-2020-results-press-release2020-11-05T07:10Znever https://rovi.es/en/periodo-medio-de-pago-proveedores2025-07-22T11:23Zyearly https://rovi.es/en/content/first-nine-months-2020-results-press-release-02021-11-02T16:11Znever https://rovi.es/en/content/first-nine-months-2020-results-presentation-02021-11-02T16:10Znever https://rovi.es/en/información-sobre-el-desarrollo-de-las-juntas-generales2021-12-30T10:43Znever https://rovi.es/en/content/rovi-reports-operating-revenue-growth-12-and-net-profit-growth-532021-11-15T18:09Znever https://rovi.es/en/content/journal-npj-schizophrenia-publishes-results-prisma-3-study-efficacy-and-safety-doria®2020-11-27T07:25Znever https://rovi.es/en/consejo-de-administración2021-12-30T10:43Znever https://rovi.es/en/content/journal-npj-schizophrenia-publishes-results-prisma-3-study-efficacy-and-safety-doriar2021-11-15T17:58Znever https://rovi.es/en/content/rovi-completes-manufacture-first-batches-moderna-vaccine2021-11-16T06:56Znever https://rovi.es/en/content/full-year-2020-financial-results2021-10-10T10:51Znever https://rovi.es/en/_reglamento-del-consejo2017-09-15T11:36Znever https://rovi.es/en/informe-anual-de-gobierno-corporativo2017-09-15T11:22Znever https://rovi.es/en/content/full-year-2020-results-press-release2021-02-24T07:03Znever https://rovi.es/en/remuneraciones-de-los-consejeros2017-09-15T11:22Znever https://rovi.es/en/comisiones-del-consejo2021-06-04T11:05Znever https://rovi.es/en/content/full-year-2020-results-press-release-02021-11-02T14:35Znever https://rovi.es/en/content/rovi-achieves-10-increase-operating-income-and-55-net-profit2021-11-12T13:15Znever https://rovi.es/en/políticas-corporativas-old2017-09-15T11:37Znever https://rovi.es/en/content/granting-partially-refundable-aid-development-new-quarterly-formulation-risperidone2021-10-10T10:53Znever https://rovi.es/en/content/incorporation-two-doctors-rdi-within-torres-quevedo-program-2020-call2021-10-10T10:53Znever https://rovi.es/en/content/update-doria®-regulatory-processes2021-03-02T07:12Znever https://rovi.es/en/content/update-doria®-regulatory-processes-12021-10-10T10:51Znever https://rovi.es/en/content/incorporation-doctor-rdi-within-torres-quevedo-program-2018-call2021-03-09T17:55Znever https://rovi.es/en/content/incorporation-doctor-rdi-within-torres-quevedo-program2021-10-10T10:53Znever https://rovi.es/en/content/rovi-participates-manufacture-active-substance-moderna’s-covid-19-vaccine2021-04-12T06:38Znever https://rovi.es/en/content/rovi-participates-manufacture-active-substance-modernas-covid-19-vaccine2021-11-12T13:11Znever https://rovi.es/en/content/january-march-2021-results2021-10-10T10:51Znever https://rovi.es/en/content/rovi-increases-its-fill-finish-capacity-covid-19-vaccine-moderna2021-04-29T05:08Znever https://rovi.es/en/content/rovi-increases-its-fill-finish-capacity-covid-19-vaccine-moderna-02021-11-12T13:10Znever https://rovi.es/en/informe-de-auditoria-cuentas-anuales-auditadas-individuales-y-consolidadas-informe-de2025-07-22T11:23Zyearly https://rovi.es/en/hechos-relevantes2021-12-30T10:30Znever https://rovi.es/en/content/first-quarter-2021-results-press-release2021-05-13T05:44Znever https://rovi.es/en/webcast-y-presentaciones2021-12-30T10:05Znever https://rovi.es/en/content/rovi-achieves-increase-29-operating-income-and-74-ebitda2021-11-12T13:08Znever https://rovi.es/en/content/first-quarter-2021-results-presentation2021-11-02T14:30Znever https://rovi.es/en/evolución-de-la-acción2025-07-22T11:23Zyearly https://rovi.es/en/histórico-de-la-cotización-bursátil2025-07-22T11:23Zyearly https://rovi.es/en/valor-de-la-acción2025-07-22T11:23Zyearly https://rovi.es/en/content/granting-partially-refundable-aid-development-new-quarterly-formulation-risperidone-02021-05-17T15:37Znever https://rovi.es/en/información-económica2025-07-22T11:23Zyearly https://rovi.es/en/content/rovi-holds-its-2021-general-shareholders-meeting2021-11-12T12:40Znever https://rovi.es/en/agenda-del-inversor2025-07-22T11:23Zyearly https://rovi.es/en/content/first-half-2021-financial-results2021-10-10T10:51Znever https://rovi.es/en/biosimilar-de-enoxaparina2025-08-06T13:42Zyearly https://rovi.es/en/content/first-half-2021-results-press-release2021-07-28T05:57Znever https://rovi.es/en/informes-anuales2025-07-22T11:23Zyearly https://rovi.es/en/content/rovi-achieves-increase-52-operating-income-and-75-ebitda2021-11-12T12:35Znever https://rovi.es/en/content/first-half-2021-results-presentation-02021-11-02T12:35Znever https://rovi.es/en/content/rovi-achieves-second-place-worldwide-sustainability-rating2021-11-12T12:32Znever https://rovi.es/en/content/rovi-achieves-second-place-worldwide-sustainability-rating-02021-08-09T08:05Znever https://rovi.es/en/content/rovi-informs-notification-particulate-matter-having-been-seen-certain-drug-product-vials2021-08-26T16:07Znever https://rovi.es/en/content/rovi-informs-notification-particulate-matter-having-been-seen-certain-drug-product-vials-02021-11-12T12:28Znever https://rovi.es/en/content/rovi-informs-evolution-investigation-particulate-matter-having-been-seen-certain-drug2021-08-29T20:50Znever https://rovi.es/en/content/rovi-informs-evolution-investigation-particulate-matter-having-been-seen-certain-drug-02021-12-14T10:01Znever https://rovi.es/en/content/rovi-informs-about-joint-statement-moderna-and-takeda-investigation-suspended-lots-vaccine2021-09-01T19:42Znever https://rovi.es/en/content/rovi-informs-about-joint-statement-moderna-takeda-investigation-suspended-lots-vaccine2021-12-15T15:54Znever https://rovi.es/en/_información-para-el-inversor2017-09-15T11:36Znever https://rovi.es/en/notas-de-prensa2021-12-30T10:06Znever https://rovi.es/en/transparencia2017-09-15T11:37Znever https://rovi.es/en/content/press-release-first-quarter-20172021-10-10T10:53Znever https://rovi.es/en/content/presentation-results-first-quarter-20172021-10-10T10:53Znever https://rovi.es/en/content/biosimilar-enoxaparin-great-opportunity-rovi2025-07-22T11:24Zyearly https://rovi.es/en/content/presentation-biosimilar-enoxaparin-rovi2021-10-10T10:53Znever https://rovi.es/en/content/2017-first-quarter-results-press-release2025-07-22T11:23Zyearly https://rovi.es/en/shareholders-investors2022-06-20T11:18Znever https://rovi.es/en/shareholders-investors/calendar2021-12-15T11:17Znever https://rovi.es/en/content/publicacion-resultados-financieros-del-periodo-9-meses-finalizado-30-septiembre-20112021-11-11T10:38Znever https://rovi.es/en/content/rovi-informs-evolution-investigation-particulate-matter-having-been-seen-certain-drug-12022-01-13T09:36Znever https://rovi.es/en/content/president-spanish-government-pedro-sanchez-makes-institutional-visit-rovis-facilities2021-11-12T13:05Znever https://rovi.es/en/content/rovi-completes-manufacture-first-batches-moderna-vaccine-eu2022-01-13T09:38Znever https://rovi.es/en/shareholders-investors/cnmv-communications2021-11-14T18:50Znever https://rovi.es/en/shareholders-investors/esg2021-11-25T09:32Znever https://rovi.es/en/shareholders-investors/corporate-governance2025-06-23T12:15Zyearly https://rovi.es/en/content/spanish-prime-minister-pedro-sanchez-makes-institutional-visit-rovis-facility-san-sebastian2021-11-15T18:00Znever https://rovi.es/en/content/recruitment-two-doctors-rd-area-under-torres-quevedo-programme-20202021-11-15T18:10Znever https://rovi.es/en/content/rovi-obtains-second-place-global-sustainability-rating2021-11-15T18:15Znever https://rovi.es/en/content/rovi-will-donate-million-surgical-masks-ministry-health2021-11-16T06:44Znever https://rovi.es/en/shareholders-investors/the-share/evolution2025-05-14T16:50Zyearly https://rovi.es/en/content/12th-spain-investors-day-ceo-conference2021-11-30T12:19Znever https://rovi.es/en/content/xxviii-santander-iberian-conference2021-11-29T08:55Znever https://rovi.es/en/content/oddo-bhf-forum-20222021-11-29T08:55Znever https://rovi.es/en/content/capital-market-day-20212021-12-15T11:55Znever https://rovi.es/en/content/financial-results-first-nine-months-20212021-12-15T12:00Znever https://rovi.es/en/shareholders-investors/corporate-governance/corporate-policies2025-11-17T11:12Zyearly https://rovi.es/en/shareholders-investors/corporate-governance/notice-agenda2025-05-07T22:40Zyearly https://rovi.es/en/shareholders-investors/corporate-governance/complete-texts2021-12-08T11:26Znever https://rovi.es/en/shareholders-investors/corporate-governance/proxy-voting2025-05-08T00:08Zyearly https://rovi.es/en/shareholders-investors/corporate-governance/distance-voting2025-05-08T00:12Zyearly https://rovi.es/en/shareholders-investors/corporate-governance/shareholder-forum2025-05-08T00:17Zyearly https://rovi.es/en/shareholders-investors/corporate-governance/request-information2021-12-08T18:41Znever https://rovi.es/en/shareholders-investors/corporate-governance/gm-contents2025-06-23T11:46Zyearly https://rovi.es/en/shareholders-investors/corporate-governance/committees2025-05-08T00:22Zyearly https://rovi.es/en/shareholders-investors/corporate-governance/composition2023-06-07T17:07Znever https://rovi.es/en/shareholders-investors/corporate-governance/annual-cg-report2026-02-25T09:47Zmonthly https://rovi.es/en/shareholders-investors/corporate-governance/compensation2026-02-25T09:48Zmonthly https://rovi.es/en/content/2017-first-quarter-results-presentation2025-07-22T11:23Zyearly https://rovi.es/en/content/2021-capital-markets-day-presentation2021-12-13T17:20Znever https://rovi.es/en/content/rovi-share-buyback-program2021-12-15T12:05Znever https://rovi.es/en/content/first-nine-months-2021-results-press-release2021-12-16T16:44Znever https://rovi.es/en/content/fda-delays-its-decision-risperidone-ismr2021-12-15T15:53Znever https://rovi.es/en/content/rovi-receives-positive-opinion-chmp-okedir-treatment-schizophrenia2021-12-21T12:30Znever https://rovi.es/en/content/financial-results-full-year-20212022-02-01T15:55Znever https://rovi.es/en/content/rovi-receives-european-commissions-approval-okedir-treatment-schizophrenia2022-03-08T17:04Znever https://rovi.es/en/content/moderna-and-rovi-expand-long-term-collaboration-manufacture-mrna-medicines-over-next-ten2022-02-16T08:06Znever https://rovi.es/en/content/full-year-2021-results-press-release2022-02-23T07:57Znever https://rovi.es/en/content/rovi-was-carbon-neutral-20212022-03-04T09:17Znever https://rovi.es/en/content/decentralised-procedure-used-registration-rovis-biosimilar-enoxaparin-has-been-completed2025-07-22T11:24Zyearly https://rovi.es/en/up-to-date2022-06-29T14:17Znever https://rovi.es/en/content/first-quarter-2022-financial-results2022-04-05T12:21Znever https://rovi.es/en/content/recall-notification-lot-000190a2022-04-08T17:06Znever https://rovi.es/en/content/first-quarter-2022-results-press-release2022-05-11T05:51Znever https://rovi.es/en/content/full-year-2016-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2016-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/incorporation-two-doctors-rdi-within-torres-quevedo-program2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-announces-marketing-agreement-neparvis-spain2025-07-22T11:24Zyearly https://rovi.es/en/content/keys-rovis-annual-results2022-09-01T09:56Znever https://rovi.es/en/content/avoid-reduce-and-compensate-rovi-achieves-carbon-neutrality-20212022-09-01T09:57Znever https://rovi.es/en/content/keys-rovis-1q-2022-results2022-06-24T12:22Znever https://rovi.es/en/content/first-half-2022-financial-results2022-06-28T14:14Znever https://rovi.es/en/content/first-half-2022-results-press-release2022-07-27T06:22Znever https://rovi.es/en/content/european-investment-bank-and-rovi-spur-innovation-spanish-pharmaceutical-sector2022-07-19T09:56Znever https://rovi.es/en/content/rovi-tops-sustainalytics-sustainability-ranking-pharmaceutical-subindustry-worldwide2022-08-01T07:59Znever https://rovi.es/en/content/nine-month-period-ended-30-september-2016-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-reactivates-its-corporate-volunteering-program2022-08-09T07:10Znever https://rovi.es/en/content/keys-results-rovis-first-semester-20222022-09-14T07:00Znever https://rovi.es/en/content/glicopepton-biotech-founded-produce-compounds-high-technological-value2022-10-04T11:14Znever https://rovi.es/en/content/first-nine-months-2022-financial-results2022-10-19T12:06Znever https://rovi.es/en/content/capital-market-day-20222022-10-10T10:36Znever https://rovi.es/en/content/president-andalusian-government-juan-manel-moreno-visits-new-rovi-plant-escuzar-granada2022-10-24T10:56Znever https://rovi.es/en/content/first-nine-months-2022-results-press-release2022-11-04T06:39Znever https://rovi.es/en/content/nine-month-period-ended-30-september-2016-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/2022-capital-markets-day-presentation2022-11-23T06:14Znever https://rovi.es/en/content/rovi-launches-initiative-develop-solutions-improve-sustained-release-injectable-drug2022-12-05T09:43Znever https://rovi.es/en/content/financial-results-full-year-20222023-01-25T11:49Znever https://rovi.es/en/content/rovi-announces-marketing-agreement-mysimba-spain2025-07-22T11:24Zyearly https://rovi.es/en/content/rovis-alcala-henares-plant-receives-visit-romanian-health-minister2023-02-06T15:35Znever https://rovi.es/en/content/first-half-2016-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2022-results-press-release2023-02-21T07:11Znever https://rovi.es/en/content/rovi-informs-evaluation-process-obtain-marketing-authorisation-risvanr2023-02-16T07:36Znever https://rovi.es/en/content/rovi-and-equality-commitment-good-government2023-03-22T16:02Znever https://rovi.es/en/content/biosim-strengthens-its-national-representation-incorporation-rovi-pharmaceutical2023-03-21T12:11Znever https://rovi.es/en/content/rovi-plants-forest-2000-trees-madrid-sierra2023-03-27T09:26Znever https://rovi.es/en/content/first-half-2016-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/keys-rovis-2022-annual-results2023-04-10T15:24Znever https://rovi.es/en/content/created-chair-study-psychological-impact-and-benefits-technology-mental-health-prevention2023-04-12T07:27Znever https://rovi.es/en/content/health-and-safety-heart-our-operations2023-04-19T14:53Znever https://rovi.es/en/content/first-quarter-2024-financial-results2024-04-04T15:04Zyearly https://rovi.es/en/textos-completos-de-las-propuestas-de-acuerdos-a-tomar-y-de-la-documentación-disponible-para-el-accionista-con-anterioridad-a-la-junta2021-12-30T10:42Znever https://rovi.es/en/content/rovi-commences-clinical-development-new-three-monthly-formulation-letrozole-letrozole-lebe2023-04-25T06:29Znever https://rovi.es/en/content/rovi-leads-bioelast-consortium-approved-2021-call-projects-public-private-collaboration-mcin2025-03-19T11:01Zyearly https://rovi.es/en/content/grant-partially-reimbursable-aid-assessment-toxicity-risperidone-ismr-quarterly2023-05-08T11:12Znever https://rovi.es/en/content/2016-first-quarter-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/first-quarter-2023-results-press-release2023-05-10T06:00Znever https://rovi.es/en/content/2016-first-quarter-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-leads-biomap-consortium2025-07-22T11:24Zyearly https://rovi.es/en/content/enervit-nutrition-joint-venture-rovi-and-enervit-will-distribute-nutritional-products-spain2025-07-22T11:24Zyearly https://rovi.es/en/sustainability2026-03-03T16:48Zmonthly https://rovi.es/en/sustainability/responsible-governance2025-07-16T08:17Zyearly https://rovi.es/en/sustainability/commitment-to-people2026-02-11T12:57Zmonthly https://rovi.es/en/sustainability/environmental-commitment2026-02-11T13:05Zmonthly https://rovi.es/en/content/full-year-2015-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/get-know-laboratorios-rovi-and-keys-its-business-project2023-05-25T07:21Znever https://rovi.es/en/ethics-channel2024-08-02T10:49Zyearly https://rovi.es/en/content/rovi-ratifies-its-commitment-environmentally-sustainable-company2023-06-22T07:22Znever https://rovi.es/en/content/full-year-2015-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/first-half-2023-financial-results2023-06-29T07:44Znever https://rovi.es/en/content/laboratorios-rovi-makes-active-contribution-sustainable-development2023-07-13T08:35Znever https://rovi.es/en/content/first-half-2023-results-press-release2023-07-26T06:31Znever https://rovi.es/en/content/rovi-informs-evaluation-process-obtain-marketing-authorisation-risvanr-02023-07-28T07:30Znever https://rovi.es/en/content/rovi-takes-first-place-sustainalytics-world-esg-risk-ranking-second-year-running2023-08-04T06:47Znever https://rovi.es/en/content/laboratorios-rovi-we-are-driving-sustainable-growth-our-2023-2025-esg-master-plan2023-08-30T08:23Znever https://rovi.es/en/content/first-nine-months-2023-financial-results2023-09-27T10:41Znever https://rovi.es/en/content/first-nine-months-2023-results-press-release2023-11-08T06:40Znever https://rovi.es/en/content/six-pillars-laboratorios-rovis-employment-policy2023-12-21T14:48Znever https://rovi.es/en/content/rovi-laboratories-reinforces-its-volunteering-activities-20232024-01-15T08:52Znever https://rovi.es/en/content/financial-results-full-year-20232024-01-30T08:17Znever https://rovi.es/en/content/technologist-joins-our-rdi-program-thanks-emplea-program2025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2023-results-press-release2024-02-27T08:54Znever https://rovi.es/en/content/rovi-insud-pharma-and-innvierte-cdti-create-company-research-and-development-advanced2024-03-12T16:22Znever https://rovi.es/en/content/rovi-receives-fdas-approval-risvanr-treatment-schizophrenia2024-04-02T05:10Znever https://rovi.es/en/content/nine-month-period-ended-30-september-2015-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-announces-agreement-manufacture-pre-filled-syringes2024-04-25T07:54Zyearly https://rovi.es/en/content/first-three-months-2024-results-press-release2024-05-08T05:39Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2015-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/first-half-2015-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/first-half-2024-financial-results2024-05-24T11:58Zyearly https://rovi.es/en/content/first-half-2015-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-completes-its-new-escuzar-plant-including-sodium-heparin-production-facility2024-06-20T07:25Zyearly https://rovi.es/en/content/rovi-forecasts-potential-risperidone-ismr-sales-between-200-and-300-million-euros-globally2024-06-24T08:15Zyearly https://rovi.es/en/content/laboratorios-rovi-responsible-company-committed-environment2024-06-28T08:16Zyearly https://rovi.es/en/content/rovi-will-present-positive-results-risperidone-ismr-and-bemiparin-12th-eacpt-congress2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-invests-60-million-euros-expand-production-capacity-its-san-sebastian-reyes-plant-3152024-07-11T11:46Zyearly https://rovi.es/en/content/first-half-2024-results-press-release2024-07-31T05:46Zyearly https://rovi.es/en/content/rovi-announces-upcoming-marketing-orvatez-spain2025-07-22T11:24Zyearly https://rovi.es/en/content/commitment-job-creation-rovi-laboratories2024-09-06T11:35Zyearly https://rovi.es/en/content/first-nine-months-2024-financial-results2024-11-07T08:36Zyearly https://rovi.es/en/content/rovi-agrees-acquire-assets-manufacturing-plant-san-sebastian-reyes2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-completes-strategic-review-its-cdmo-business2024-10-24T05:54Zyearly https://rovi.es/en/content/first-nine-months-2024-results-press-release2024-11-07T07:28Zyearly https://rovi.es/en/content/financial-results-full-year-20242025-01-15T11:47Zyearly https://rovi.es/en/content/capital-market-day-20252025-01-16T13:59Zyearly https://rovi.es/en/content/corporate-volunteering-program-has-reinforced-rovis-social-commitment-20242025-01-16T15:37Zyearly https://rovi.es/en/content/2015-first-quarter-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/2015-first-quarter-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/2024-results-press-release2025-02-25T07:15Zyearly https://rovi.es/en/content/2025-capital-markets-day-presentation2025-03-25T07:44Zyearly https://rovi.es/en/content/first-quarter-2025-financial-results2025-03-27T15:40Zyearly https://rovi.es/en/content/full-year-2014-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/first-three-months-2025-results-press-release2025-05-08T06:03Zyearly https://rovi.es/en/content/full-year-2014-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/first-half-2025-financial-results2025-06-13T11:12Zyearly https://rovi.es/en/content/rovi-held-its-2025-general-shareholders-meeting2025-06-18T13:08Zyearly https://rovi.es/en/content/transparency-and-traceability-non-financial-information-how-rovis-sciinf-works2025-06-20T12:58Zyearly https://rovi.es/en/content/final-decision-award-aid-363-million-euros-rovis-laisolid-project-subsidised-cdti2025-07-10T12:21Zyearly https://rovi.es/en/content/rovi-receive-363-million-euros-research-prolonged-release-drugs-and-new-sterile-filling2025-07-10T13:52Zyearly https://rovi.es/en/content/first-half-2025-results-press-release2025-07-24T06:04Zyearly https://rovi.es/en/content/rovi-announces-agreement-market-volutsa-spain2025-07-22T11:24Zyearly https://rovi.es/en/content/sustainable-decisions-fully-integrated-rovis-management-model2025-09-03T09:45Zyearly https://rovi.es/en/content/first-nine-months-2025-financial-results2025-09-04T14:53Zyearly https://rovi.es/en/content/rovi-announces-acquisition-injectable-drug-product-manufacturing-site-phoenix-arizona-usa2025-10-02T15:02Zyearly https://rovi.es/en/content/rovi-announces-acquisition-injectable-drug-product-manufacturing-site-phoenix-arizona-usa-02025-09-30T09:50Zyearly https://rovi.es/en/content/rois-new-brand-identity-growing-cdmo-company2025-10-03T09:46Zyearly https://rovi.es/en/content/rovi-announces-collaboration-roche-manufacture-new-medicine-development2025-10-21T13:49Zyearly https://rovi.es/en/content/first-nine-months-2025-results-press-release2025-11-06T12:17Zyearly https://rovi.es/en/content/rovi-announces-positive-results-risperidone-ism-new-trial2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-releases-press-release-relation-signing-definitive-collaboration-agreement-roche2025-11-18T07:26Zyearly https://rovi.es/en/content/financial-results-full-year-20252026-01-20T09:23Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2014-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2014-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/2025-results-press-release2026-02-25T07:34Zmonthly https://rovi.es/en/content/rovi-reinforces-its-social-impact-2025-through-corporate-volunteering2026-03-06T13:09Zmonthly https://rovi.es/en/content/first-half-2014-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/first-quarter-2026-financial-results2026-03-13T09:45Zmonthly https://rovi.es/en/content/rovi-announces-closing-asset-purchase-agreement-entered-september-2025-acquisition2026-04-01T07:40Zdaily https://rovi.es/en/content/first-half-2014-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/9m-2011-interim-statement2025-07-22T11:24Zyearly https://rovi.es/en/content/2014-first-quarter-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/2014-first-quarter-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/_reglamento-interno-de-conducta-relativo-a-la-operativa-en-el-mercado-de-valores2017-09-15T11:36Znever https://rovi.es/en/content/nine-month-period-ended-30-september-2011-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2013-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2013-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/results-final-analysis-abel-phase-ii-clinical-trial2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-announces-exclusive-commercialization-medikinet-medicebran-spain2025-07-22T11:24Zyearly https://rovi.es/en/content/alentia-biotech-plans-construct-national-production-centre-supply-spanish-population-flu2025-07-22T11:24Zyearly https://rovi.es/en/content/new-results-shift-study-heart-failure-patients-corlentor2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-announces-agreement-market-hirobriz-breezhaler-ulunar-breezhaler-espana2025-07-22T11:24Zyearly https://rovi.es/en/content/2011-first-half-results2025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2013-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/2011-first-half-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2013-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/2011-first-quarter-results2025-07-22T11:24Zyearly https://rovi.es/en/content/2013-first-half-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/2011-first-quarter-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/2013-first-half-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/2010-full-year-results2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-exercises-purchase-option-over-rhodogil2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-signs-contract-farmalider-manufacturing-oral-forms2025-07-22T11:24Zyearly https://rovi.es/en/content/marketing-absorcol-and-vytorin-first-five-licenses-msd2025-07-22T11:24Zyearly https://rovi.es/en/content/2013-first-quarter-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/results-phase-i-trial-oral-bemiparin-based-ocap-technology2025-07-22T11:24Zyearly https://rovi.es/en/content/2013-first-quarter-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/2012-full-year-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/2012-full-year-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/9m-2012-interim-statement2025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2012-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-obtains-fda-approval-its-injectables-plant2025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-and-ucb-end-their-commercial-relationship-regards-cimzia2025-07-22T11:24Zyearly https://rovi.es/en/content/2012-first-half-results2025-07-22T11:24Zyearly https://rovi.es/en/content/2012-first-half-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/2012-first-quarter-results2025-07-22T11:24Zyearly https://rovi.es/en/content/2012-first-quarter-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/2011-full-year-results-press-release2025-07-22T11:24Zyearly https://rovi.es/en/content/2011-full-year-results-presentation2025-07-22T11:24Zyearly https://rovi.es/en/content/corlentorr-receives-approval-use-heart-failure2025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2016-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2016-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/incorporation-two-doctors-rdi-within-torres-quevedo-program-02025-07-22T11:24Zyearly https://rovi.es/en/content/presentation-related-rovi-enoxaparin-biosimilar2025-07-22T11:24Zyearly https://rovi.es/en/content/biosimilar-enoxaparin-great-opportunity-rovi-02025-07-22T11:24Zyearly https://rovi.es/en/content/decentralised-procedure-used-registration-rovis-biosimilar-enoxaparin-has-been-completed-02025-07-22T11:24Zyearly https://rovi.es/en/content/2016-first-quarter-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/2016-first-quarter-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/enervit-nutrition-joint-venture-rovi-and-enervit-will-distribute-nutritional-products-02025-07-22T11:24Zyearly https://rovi.es/en/content/first-half-2016-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/first-half-2016-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2015-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2015-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2016-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2016-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-announces-marketing-agreement-mysimba-spain-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-announces-marketing-agreement-neparvis-spain-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-leads-biomap-consortium-02025-07-22T11:24Zyearly https://rovi.es/en/content/2015-first-quarter-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/2015-first-quarter-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/first-half-2015-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/first-half-2015-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2014-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2014-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2015-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2015-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-agrees-acquire-assets-manufacturing-plant-san-sebastian-reyes-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-announces-agreement-market-volutsa-spain-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-announces-upcoming-marketing-orvatez-spain-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-will-present-positive-results-risperidone-ismr-and-bemiparin-12th-eacpt-congress-02025-07-22T11:24Zyearly https://rovi.es/en/content/technologist-joins-our-rdi-program-thanks-emplea-program-02025-07-22T11:24Zyearly https://rovi.es/en/content/2014-first-quarter-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/2014-first-quarter-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/first-half-2014-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/first-half-2014-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2013-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/full-year-2013-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2014-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2014-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-announces-positive-results-risperidone-ism-new-trial-02025-07-22T11:24Zyearly https://rovi.es/en/content/2012-full-year-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/2012-full-year-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/2013-first-half-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/2013-first-half-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/2013-first-quarter-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2013-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2013-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-announces-agreement-market-hirobriz-breezhaler-ulunar-breezhaler-espana-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-announces-exclusive-commercialization-medikinet-medicebran-spain-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-exercises-purchase-option-over-rhodogil-02025-07-22T11:24Zyearly https://rovi.es/en/content/9m-2012-interim-statement-02025-07-22T11:24Zyearly https://rovi.es/en/content/2011-full-year-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/2011-full-year-results-press-release-02025-07-22T11:24Zyearly https://rovi.es/en/content/2012-first-half-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/2012-first-half-results-02025-07-22T11:24Zyearly https://rovi.es/en/content/2012-first-quarter-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/2012-first-quarter-results-02025-07-22T11:24Zyearly https://rovi.es/en/content/corlentorr-receives-approval-use-heart-failure-02025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2012-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-and-ucb-end-their-commercial-relationship-regards-cimzia-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-obtains-fda-approval-its-injectables-plant-02025-07-22T11:24Zyearly https://rovi.es/en/content/9m-2011-interim-statement-02025-07-22T11:24Zyearly https://rovi.es/en/content/2010-full-year-results-02025-07-22T11:24Zyearly https://rovi.es/en/content/2011-first-half-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/2011-first-half-results-02025-07-22T11:24Zyearly https://rovi.es/en/content/2011-first-quarter-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/2011-first-quarter-results-02025-07-22T11:24Zyearly https://rovi.es/en/content/alentia-biotech-plans-construct-national-production-centre-supply-spanish-population-flu-02025-07-22T11:24Zyearly https://rovi.es/en/content/marketing-absorcol-and-vytorin-first-five-licenses-msd-02025-07-22T11:24Zyearly https://rovi.es/en/content/new-results-shift-study-heart-failure-patients-corlentor-02025-07-22T11:24Zyearly https://rovi.es/en/content/nine-month-period-ended-30-september-2011-results-presentation-02025-07-22T11:24Zyearly https://rovi.es/en/content/results-final-analysis-abel-phase-ii-clinical-trial-02025-07-22T11:24Zyearly https://rovi.es/en/content/results-phase-i-trial-oral-bemiparin-based-ocap-technology-02025-07-22T11:24Zyearly https://rovi.es/en/content/rovi-signs-contract-farmalider-manufacturing-oral-forms-02025-07-22T11:24Zyearly